parent_smiles,parent_id,parent_name,child_id,child_name,child_smiles,set
CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,DB09194,Etoperidone,DBMET01878,1-(3-chlorophenyl) piperazine,Clc1cccc(N2CCNCC2)c1,train
C[C@@H]1NP(=O)(OC[C@H]2O[C@@](C#N)(c3ccc4c(N)ncnn34)[C@H](O)[C@@H]2O)OC1=O,DBMET03215,Remdesivir cyclic anhydride,DBMET03035,Remdesivir Alanine Metabolite (Ala-Met; GS-704277),C[C@H](N[P@@](=O)([O-])OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)C(=O)[O-],train
CCOC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)[C@@H](N)Cc1ccc(N(CCCl)CCCl)cc1,DB16627,Melphalan flufenamide,DBMET03272,Desethyl Melphalan Flufenamide,N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)O,train
C[N+](C)([O-])CC/C=C1\c2ccccc2COc2ccccc21,DBMET00844,Doxepin N-oxide,DBMET00845,Doxepin N-oxide glucuronide,C[N+](C)(CC/C=C1\c2ccccc2COc2ccccc21)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,train
CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C(O)[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,DBMET02469,3-alpha-isopravastatin,DBMET02471,7-hydroxy-3-alpha-isopravastatin,CC[C@H](C)C(=O)O[C@H]1C(O)CC=C2C=C(O)[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,train
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,DB01065,Melatonin,DBMET01359,5-Methoxytryptamine,COc1ccc2[nH]cc(CCN)c2c1,train
CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,DB00672,Chlorpropamide,DBMET00201,4-Chlorobenzenesulfonylurea,NC(=O)NS(=O)(=O)c1ccc(Cl)cc1,train
NC(=O)NO,DB01005,Hydroxyurea,DBMET01482,Ammonia,N,train
COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)O)C1c1ccccc1[N+](=O)[O-],DBMET01949,Aranidipine M-1,DBMET01951,Aranidipine M-4,COC(=O)c1c(C)nc(C)c(C(=O)OCC(C)O)c1-c1ccccc1[N+](=O)[O-],train
CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1,DB00273,Topiramate,DBMET02911,"4,5-Desisopropylidene topiramate",CC1(C)O[C@H]2[C@H](O)[C@H](O)CO[C@@]2(COS(N)(=O)=O)O1,train
O=C1CCC(NC(=O)c2ccccc2C(=O)O)C(=O)N1,DBMET01118,alpha-(o-carboxybenzamido)glutarimide,DB02746,Phthalic Acid,O=C(O)c1ccccc1C(=O)O,train
CCc1c(Cl)c(O)c(Cl)c(O)c1C(=O)O[C@H]1[C@H](O)[C@H](OC)[C@H](OC/C2=C\C=C\C[C@H](O)/C(C)=C/[C@H](CC)[C@@H](O[C@@H]3OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]3O)/C(C)=C/C(C)=C/C[C@@H]([C@@H](C)O)OC2=O)O[C@@H]1C,DB08874,Fidaxomicin,DBMET00972,OP-1118,CCc1c(Cl)c(O)c(Cl)c(O)c1C(=O)O[C@H]1[C@H](O)[C@H](OC)[C@H](OC/C2=C\C=C\C[C@H](O)/C(C)=C/[C@H](CC)[C@@H](O[C@@H]3OC(C)(C)[C@@H](O)[C@H](O)[C@@H]3O)/C(C)=C/C(C)=C/C[C@@H]([C@@H](C)O)OC2=O)O[C@@H]1C,train
CC(=O)N1CCN(c2ccc(OCC3COC(CN4C=NC(O)C4O)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DBMET02665,Ketoconazole dihydroxyl intermediate,DBMET02667,M3 (Ketoconazole),CC(=O)N1CCN(c2ccc(OCC3COC(CNC=N)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,train
NNc1nncc2ccccc12,DB01275,Hydralazine,DBMET02815,Phthalazinone,O=c1[nH]ncc2ccccc12,train
CNC1(c2ccccc2Cl)CC(O)CCC1=O,DBMET00192,4-Hydroxyketamine,DBMET01308,4-Hydroxynorketamine,NC1(c2ccccc2Cl)CC(O)CCC1=O,train
CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1,DB15133,Tepotinib,DBMET03251,Tepotinib M508 metabolite,C[N+]1([O-])CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1,train
O=C(O)CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1,DB07565,Chloramphenicol succinate,DB00446,Chloramphenicol,O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl,train
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O,DB00615,Rifabutin,DBMET00696,25-O-deacetylrifabutin,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](O)[C@@H]1C)C4=O,train
CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1,DB00518,Albendazole,DBMET00791,albendazole sulfoxide,CCCS(=O)c1ccc2[nH]c(NC(=O)OC)nc2c1,train
CN[C@@H](C)[C@H](O)c1ccccc1,DB01364,Ephedrine,DBMET00540,Norephedrine,C[C@@H](N)[C@@H](O)c1ccccc1,train
Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2,DB01215,Estazolam,DBMET00732,4-hydroxy-estazolam,OC1N=C(c2ccccc2)c2cc(Cl)ccc2-n2cnnc21,train
CC1(C)CC(=O)N(CCCCN2CCN(c3ncc(O)cn3)CC2)C(=O)C1,DBMET03725,5-OH-gepirone,DBMET03724,"3',5-di-OH-gepirone",CC1(C)CC(=O)N(CCCCN2CCN(c3ncc(O)cn3)CC2)C(=O)C1O,train
CCC/N=C1\S/C(=C\c2ccc(OC[C@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C,DB12016,Ponesimod,DBMET03308,Ponesimod M6 Metabolite,CCC/N=C1\SC(Cc2ccc(OC[C@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C,train
Nc1ccc([C@@H](O)[C@H](N)CO)cc1,DBMET03165,Chloramphenicol Aryl Amine,DBMET03166,Chloramphenicol Aryl Amide,CC(=O)Nc1ccc([C@@H](O)[C@H](N)CO)cc1,train
C=CCC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](/C=C(/C)C(=O)O)C2(C)C)CC1=O,DBMET02078,M3 (Bioallethrin),DBMET02082,M7 (Bioallethrin),C=CCC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](/C=C(/C)C(=O)O)C2(C)CO)CC1=O,train
CC(N)Cc1ccccc1,DB00182,Amphetamine,DBMET02222,Phenylacetone,CC(=O)Cc1ccccc1,train
OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O,DB11217,Arbutin,DB01914,D-glucose,O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,train
CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,DB11986,Entrectinib,DBMET02745,ENB577b,C[NH+]1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1O,train
COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCC(C)(C)S)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(N=C(O)O1)[C@H](OC)/C=C\C=C(\C)C2,DBMET03570,DM4,DBMET03571,S-methyl-DM4,COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCC(C)(C)SC)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(N=C(O)O1)[C@H](OC)/C=C\C=C(\C)C2,train
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O,DB04573,Estriol,DBMET00604,Estriol 3-sulfate 16-glucuronide,C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1C[C@@H](OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)[C@@H]2O,train
CN(C)CC/C=C1\c2ccccc2CSc2ccccc21,DB09167,Dosulepin,DBMET01519,Dosulepin S-oxide,CN(C)CC/C=C1\c2ccccc2CS(=O)c2ccccc21,train
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,DB09074,Olaparib,DBMET03439,Olaparib M1 metabolite,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCNCC1,train
CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O,DB06716,Fospropofol,DBMET00532,Phosphate,O=P([O-])([O-])[O-],train
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O,DB00655,Estrone,DBMET00569,Estrone glucuronide,C[C@]12CC[C@@H]3c4ccc(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O)cc4CC[C@H]3[C@@H]1CCC2=O,train
COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1,DB06480,Prucalopride,DBMET02202,Hydroxy prucalopride,COCCCN1CCC(NC(=O)c2c(O)c(Cl)c(N)c3c2OCC3)CC1,train
Nc1ccc(S(=O)(=O)Nc2ccc(O)cn2)cc1,DBMET03575,5'-hydroxysulfapyridine,DBMET03576,5'-hydroxysulfapyridine-O-glucuronide,Nc1ccc(S(=O)(=O)Nc2ccc(OC3OC(C(=O)O)C(O)C(O)C3O)cn2)cc1,train
O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,DB00614,Furazolidone,DBMET00706,3-amino-2-oxazolidone,NN1CCOC1=O,train
COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1,DB12364,Betrixaban,DBMET01536,PRT062803,COc1ccc(N)c(C(=O)Nc2ccc(Cl)cn2)c1,train
N=C1CCCN1Cc1[nH]c(=O)[nH]c(=O)c1Cl,DB09343,Tipiracil,DBMET01853,6-(hydroxymethyl)uracil,O=c1cc(CO)[nH]c(=O)[nH]1,train
c1ccc(C(O[C@H]2C[C@H]3CC[C@@H](C2)N3)c2ccccc2)cc1,DBMET02260,N-desmethylbenztropine,DBMET02261,N-desmethyl-4'-hydroxy benztropine,O[C@]1(OC(c2ccccc2)c2ccccc2)C[C@H]2CC[C@@H](C1)N2,train
COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,DB00674,Galantamine,DBMET03148,Galantaminone,COc1ccc2c3c1O[C@H]1CC(=O)C=C[C@@]31CCN(C)C2,train
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl,DB00764,Mometasone,DBMET00759,6-beta-hydroxy-mometasone furoate,C[C@@H]1C[C@H]2[C@@H]3C(O)CC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl,train
CC1=C(C/C=C(\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=O)c2ccccc2C1=O,DB01022,Phylloquinone,DBMET03365,Vitamin K 5 Carbon Metabolite,CC1=C(C/C=C(\C)C(=O)O)C(=O)c2ccccc2C1=O,train
COc1cc2nc(N3CCNCC3)nc(N)c2cc1OC,DBMET02358,Free Piperazine Derivative,DBMET02359,Diamine Metabolite Of The Piperazine Compound,COc1cc2nc(N)nc(N)c2cc1OC,train
N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,DB01042,Melphalan,DBMET03273,Monohydroxy-melphalan,N[C@@H](Cc1ccc(N(CCO)CCCl)cc1)C(=O)O,train
O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,DB01219,Dantrolene,DBMET00751,5-hydroxydantrolene,O=C1N=C(O)C(O)N1/N=C/c1ccc(-c2ccc([N+](=O)[O-])cc2)o1,train
CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,DB08822,Azilsartan medoxomil,DBMET03335,Azilsartan,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nc(=O)o[nH]2)cc1,train
N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,DB11763,Momelotinib,DBMET03713,Momelotinib M19 metabolite,O=C(O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,train
N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,DB00509,Dextrothyroxine,DBMET00586,Thyroxine glucuronide,N[C@@H](Cc1cc(I)c(Oc2cc(I)c(OC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)c(I)c2)c(I)c1)C(=O)O,train
CCCCCCC(=O)[O-],DBMET03172,Heptanoate,DBMET03175,Acetyl Coenzyme A,CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O,train
O=C1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CCN1,DBMET02517,oxociprofloxacin,DBMET02515,Desethylene ciprofloxacin,NCCNc1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1,train
N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,DB14568,Ivosidenib,DBMET03502,Ivosidenib M30 metabolite,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(N)=O)c2ccccc2Cl)c1,train
COc1ccc2c3c1O[C@H]1C(OC(=O)c4ccccc4)=CC[C@@H]4[C@@H](C2)N(C)CC[C@@]341,DB15465,Benzhydrocodone,DB00956,Hydrocodone,COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314,train
C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,DB01197,Captopril,DBMET00803,captopril-cysteine disulfide,C[C@H](CSSC[C@H](N)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O,train
Cc1oc(=O)oc1COC(=O)N1CC[C@@H](N2CC/C(=C\C3=C(C(=O)O)N4C(=O)[C@@H](NC(=O)/C(=N\O)c5nsc(N)n5)[C@H]4SC3)C2=O)C1,DB14733,Ceftobiprole medocaril,DB04918,Ceftobiprole,Nc1nc(/C(=N/O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(/C=C4\CCN([C@@H]5CCNC5)C4=O)CS[C@H]23)ns1,train
COc1ccc(CN2CCNCC2)c(O)c1OC,DBMET03343,2-desmethyltrimetazidine,DBMET03346,2-desmethyltrimetazidine O-sulphate,COc1ccc(CN2CCNCC2)c(OS(=O)(=O)[O-])c1OC,train
CC(C)(CO)C(O)C(=O)NCCCO,DB11204,Panthenol,DB01783,Pantothenic acid,CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)O,train
COc1ncc(N2CCc3ncnc(N)c3C2)cc1C(F)(F)F,DBMET03655,Leniolisib M43 metabolite,DBMET03656,Leniolisib M48 metabolite,Nc1ncnc2c1CN(c1cnc(O)c(C(F)(F)F)c1)CC2,train
NC(=O)CCC(NC(=O)c1ccccc1C(=O)O)C(=O)O,DBMET01120,2-(o-carboxybenzamido)glutaramic acid,DB02746,Phthalic Acid,O=C(O)c1ccccc1C(=O)O,train
NCCc1ccc(O)c(O)c1,DB00988,Dopamine,DBMET00573,Dopamine 3-O-sulfate,NCCc1ccc(O)c(OS(=O)(=O)O)c1,train
CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C,DB04839,Cyproterone acetate,DBMET00672,15beta-hydroxycyproterone acetate,CC(=O)O[C@]1(C(C)=O)CC(O)[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)C5CC5[C@]4(C)[C@H]3CC[C@@]21C,train
O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl,DB00446,Chloramphenicol,DBMET03158,Chloramphenicol 3-acetate,CC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1,train
CN[C@@H](C)Cc1ccccc1,DB01577,Metamfetamine,DBMET00733,4-hydroxyamphetamine,CC(N)Cc1ccc(O)cc1,train
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC,DB00409,Remoxipride,DBMET03192,Remoxipride Metabolite FLA 838,COc1ccc(Br)c(OC)c1C(=O)NC[C@@H]1CCCN1,train
Cc1cn[nH]c1,DB01213,Fomepizole,DBMET00728,4-carboxypyrazole,O=C(O)c1cn[nH]c1,train
O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,DB00126,Ascorbic acid,DBMET03074,Dehydroascorbate,O=C1O[C@H]([C@@H](O)CO)C(=O)C1=O,train
COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O,DB00400,Griseofulvin,DBMET00765,6-methyl-griseofulvin,COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(C)cc(OC)c1C2=O,train
CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1,DB12532,Oxetacaine,DB01365,Mephentermine,CNC(C)(C)Cc1ccccc1,train
CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,DB00929,Misoprostol,DBMET02637,Misoprostol Acid (SC-30695),CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,train
CC(CCc1ccccc1)NCC(O)c1cc(O)c(O)c(C(N)=O)c1,DBMET02673,Labetalol 3-hydroxylated Metabolite (VI),DBMET02676,Labetalol Theoretical Metabolite (IX),CC(CCc1ccccc1)n1ccc2cc(O)c(O)c(C(N)=O)c21,train
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,DB00246,Ziprasidone,DBMET02989,"3-(piperazine-1-yl)-1,2-benzisothiazole",c1ccc2c(N3CCNCC3)nsc2c1,train
CC(C)NCC(O)COc1cccc2ccccc12,DB00571,Propranolol,DBMET02587,α-Naphthoxylactic Acid,O=C(O)C(O)COc1cccc2ccccc12,train
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,DB00783,Estradiol,DBMET00576,2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COc1cc2c(cc1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,train
CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1OCC,DB06751,,DBMET03306,6-desethyl-drotaverine,CCOc1cc2c(cc1O)CCN/C2=C\c1ccc(OCC)c(OCC)c1,train
CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,DB08932,Macitentan,DBMET03420,M3,Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,train
CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1,DB13729,Camostat,DBMET03117,4-(4-guanidinobenzoyloxy)phenylacetic Acid,N=C(N)Nc1ccc(C(=O)Oc2ccc(CC(=O)O)cc2)cc1,train
CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,DB00421,Spironolactone,DBMET02481,7-alpha-thiospironolactone,C[C@]12CCC(=O)C=C1C[C@@H](S)[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]21CCC(=O)O1,train
CC(C)(CO)[C@@H](O)C(=O)NCCCO,DB09357,Dexpanthenol,DB01783,Pantothenic acid,CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)O,train
CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(O)c(C(F)(F)F)c2)CC3)C1,DBMET03657,Leniolisib M1 metabolite,DBMET03656,Leniolisib M48 metabolite,Nc1ncnc2c1CN(c1cnc(O)c(C(F)(F)F)c1)CC2,train
CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)O[C@H]2C[C@H]1O,DB01240,Epoprostenol,DBMET00557,6-Keto-PGF1-alpha,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](CC(=O)CCCCC(=O)O)[C@@H](O)C[C@H]1O,train
CCOc1ncc(C)c2c1[C@H](c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,DB16165,Finerenone,DBMET03398,Finerenone M10 Metabolite,CCOc1ncc(C(=O)O)c2c1[C@H](c1ccc(C#N)cc1O)C(C(N)=O)=C(CO)N2,train
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1O,DBMET02549,4-hydroxy-all-trans-retinoic acid,DBMET02550,4-oxo-all-trans-retinoic acid,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1=O,train
OCCN(CCO)CCO,DB13747,Trolamine,DBMET02085,Glucuronide Conjugate (Trolamine),O=C(O)[C@H]1OC(OCCN(CCO)CCO)[C@H](O)[C@@H](O)[C@@H]1O,train
CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C,DB00296,Ropivacaine,DBMET01742,PPX,Cc1cccc(C)c1NC(=O)[C@@H]1CCCCN1,train
CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O,DB00374,Treprostinil,DBMET03508,Treprostinil metabolite HU4,O=C(O)C/C=C/CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O,train
C=C1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]2(C)[C@@]1(OC(C)=O)C(C)=O,DB14583,Segesterone acetate,DBMET02130,"3β, 5α-tetrahydrosegesterone acetate",C=C1C[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@@H]4[C@H]3CC[C@]2(C)[C@@]1(OC(C)=O)C(C)=O,train
CC(C)C(=O)OC[C@H]1O[C@@H](n2cc/c(=N/O)[nH]c2=O)[C@H](O)[C@@H]1O,DB15661,Molnupiravir,DB15660,N4-Hydroxycytidine,O=c1nc(NO)ccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,train
COc1ccc(Br)c(OC)c1C(=O)NC[C@@H]1CCC(=O)N1,DBMET03194,Remoxipride Metabolite NCL 118,DBMET03196,Remoxipride Metabolite NCM 009,COc1ccc(Br)c(OC)c1C(=O)NC[C@]1(O)CCC(=O)N1,train
Cc1ccc2c(Cl)cc(Cl)c(O)c2n1,DB13306,Chlorquinaldol,DBMET02452,Chorquinaldol Sulfate Metabolite,Cc1ccc2c(Cl)cc(Cl)c(OS([O-])([O-])[O-])c2n1,train
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,DB00477,Chlorpromazine,DBMET00822,dedimethylchlorpromazine,NCCCN1c2ccccc2Sc2ccc(Cl)cc21,train
N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,DB04876,Vildagliptin,DBMET03320,Vildagliptin M15.3 metabolite,O=C(O)CNC12CC3CC(CC(O)(C3)C1)C2,train
O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,DB01068,Clonazepam,DBMET03610,3-hydroxy-clonazepam,O=C1Nc2ccc([N+](=O)[O-])cc2C(c2ccccc2Cl)=NC1O,train
Cc1ccc(/C=C2/C(=O)C3(C)CCC2C3(C)C)cc1,DB11219,Enzacamene,DBMET02091,3-(4-hydroxymethylbenzylidene)camphor,CC12CCC(/C(=C\c3ccc(CO)cc3)C1=O)C2(C)C,train
C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,DB14681,Cortisone,DBMET02902,Tetrahydrocortisone,C[C@]12CC[C@@H](O)C[C@H]1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,train
NC(CCS[Pt]1(SCCC(N)C(=O)O)N[C@@H]2CCCC[C@H]2N1)C(=O)O,DBMET03688,DACH platinum methionine,DBMET03689,DACH platinum bis(Met) complex,O=C(O)C1CCS[Pt]23SCCC(C(=O)O)N2[C@@H]2CCCC[C@H]2N13,train
NCCc1ccccc1,DB04325,Phenethylamine,DB09269,Phenylacetic acid,O=C(O)Cc1ccccc1,train
CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,DB11703,Acalabrutinib,DBMET02885,Acalabrutinib M5 Metabolite (ACP-5530),C/C(=C/C(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,train
O=C(O)c1cc(O)c2c(c1)Cc1cccc(O)c1C2=O,DB13175,Rheinanthrone,DBMET01449,Sennidin A,O=C(O)c1cc(O)c2c(c1)C(C1c3cccc(O)c3C(=O)c3c(O)cc(C(=O)O)cc31)c1cccc(O)c1C2=O,train
O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1,DB14028,Nordazepam,DBMET01219,Nordiazepam O-glucuronide,O=C(O)[C@H]1OC(OC2CN=C(c3ccccc3)c3cc(Cl)ccc3N2)[C@H](O)[C@@H](O)[C@@H]1O,train
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,DB00619,Imatinib,DBMET03526,M42.2 imatinib,Cc1ccc(NC(=O)c2ccc(C(=O)O)cc2)cc1Nc1nccc(-c2cccnc2)n1,train
CNCCC(c1ccccc1)c1ccccn1,DBMET02635,N-desmethylpheniramine,DBMET02636,N-didesmethylpheniramine,NCCC(c1ccccc1)c1ccccn1,train
Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](CO)OC4=O)cc3F)cn2)n1,DB14569,Tedizolid,DBMET03123,Tedizolid sulphate,Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](C=S(=O)([O-])[O-])OC4=O)cc3F)cn2)n1,train
Cc1onc(-c2ccccc2)c1-c1ccc(S(=O)O)cc1,DBMET01340,Valdecoxib metabolite M7,DBMET01341,Valdecoxib metabolite M8,Cc1onc(-c2ccccc2)c1-c1ccc(S(=O)(=O)O)cc1,train
CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,DB08882,Linagliptin,DBMET02387,Linagliptin M503(1),CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C(=O)O)c3ccccc3n1)c(=O)n2C,train
CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1,DB00863,Ranitidine,DBMET02353,Ranitidine N-Oxide,CN/C(=C\[N+](=O)[O-])NCCSCc1ccc(C[N+](C)(C)[O-])o1,train
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)O)CC3,DBMET03406,Deoxydaunorubicinol aglycone,DBMET03406,Deoxydaunorubicinol aglycone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)O)CC3,train
C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,DB00635,Prednisone,DBMET02863,6α-hydroxy-prednisone (M-XIII),C[C@]12C=CC(=O)C=C1[C@@H](O)C[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,train
NC(=O)N1c2ccccc2CC(=O)c2ccccc21,DB00776,Oxcarbazepine,DBMET02807,Oxcarbazepine sulfate metabolite,NC(=O)N1c2ccccc2C=C(OS(=O)(=O)[O-])c2ccccc21,train
COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,DB01162,Terazosin,DBMET02358,Free Piperazine Derivative,COc1cc2nc(N3CCNCC3)nc(N)c2cc1OC,train
COc1ccc(N)c(C(=O)Nc2ccc(Cl)cn2)c1,DBMET01536,PRT062803,DBMET01538,PRT062982,COc1cc(O)c(N)c(C(=O)Nc2ccc(Cl)cn2)c1,train
O=S1(=O)CCNCN1,DBMET03764,Taurultam,DBMET03766,Taurinamide,NCCS(N)(=O)=O,train
COc1ccc(CN2CCNCC2)c(OC)c1OC,DB09069,Trimetazidine,DBMET03340,N-formyl Trimetazidine,COc1ccc(CN2CCN(C=O)CC2)c(OC)c1OC,train
O=C1Nc2ccc([N+](=O)[O-])cc2C(c2ccccc2Cl)=NC1O,DBMET03610,3-hydroxy-clonazepam,DBMET03611,glucuronyl-3-hydroxy-clonazepam,O=C1Nc2ccc([N+](=O)[O-])cc2C(c2ccccc2Cl)=NC1OC1OC(C(=O)O)C(O)C(O)C1O,train
C[C@]12CCC(=O)C=C1[C@@H]1C[C@@H]1[C@H]1[C@@H]3[C@@H]4C[C@@H]4[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@@H]12,DB01395,Drospirenone,DBMET00741,"4,5-dihydro-drospirenone-3-sulfate",C[C@]12CCC(S(=O)(=O)O)CC1[C@@H]1C[C@@H]1C1C2CC[C@@]2(C)C1[C@@H]1C[C@@H]1C21CCC(=O)O1,train
Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](C(=O)O)OC4=O)cc3F)cn2)n1,DBMET03126,Carboxy tedizolid,DBMET03127,Ring-opened tedizolid metabolite,Cn1nnc(-c2ccc(-c3ccc(NCC(=O)O)cc3F)cn2)n1,train
CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,DB00675,Tamoxifen,DBMET02703,α-hydroxytamoxifen,CC(O)/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,train
CS[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,DBMET02483,7-alpha-thiomethylspironolactone,DBMET02485,3beta-hydroxythiomethylspironolactone,CS[C@@H]1CC2=C[C@@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,train
Cc1c(Cl)c(C)[n+]([O-])c(Cl)c1-c1noc(-c2cc(O)c(O)c([N+](=O)[O-])c2)n1,DB11632,Opicapone,DBMET03236,BIA 9-1103,Cc1c(Cl)c(C)[n+]([O-])c(Cl)c1-c1noc(-c2cc(OS(=O)(=O)O)c(O)c([N+](=O)[O-])c2)n1,train
CC#CCn1c(N2CCC[C@@H](NC(C)=O)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,DBMET02383,Linagliptin M515(1),DBMET02385,Linigliptin M531(2),CC#CCn1c(N2CCC[C@@H](NC(C)=O)C2O)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,train
C=CC(=O)NC[C@@H](CCCO)n1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,DBMET02027,PCI-45752 (M34),DBMET02028,M24,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@H](CCCO)CNC(=O)C(O)O,train
C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,DB00241,Butalbital,DBMET02453,"5-isobutyl-5-(2,3-dihydroxypropyl) barbituric acid",CC(C)CC1(CC(O)CO)C(=O)NC(=O)NC1=O,train
O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,DB00704,Naltrexone,DBMET00760,6-beta-naltrexol,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CC2)CCC314,train
COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,DB04946,Iloperidone,DBMET03772,P-88,COc1cc(C(C)O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,train
Cl[Pt]1(Cl)N[C@@H]2CCCC[C@H]2N1,DBMET03683,Dichloro DACH platinum,DBMET03684,Monoaquo DACH platinum,[OH2+][Pt]1(Cl)N[C@@H]2CCCC[C@H]2N1,train
C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,DBMET00558,Dihydrotestosterone,DBMET00593,3-alpha-Androstanediol glucuronide,C[C@]12CC[C@@H](O[C@H]3OC(C(=O)O)[C@@H](O)C(O)[C@H]3O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,train
C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,DB00860,Prednisolone,DBMET02853,6βhydroxy-prednisolone(M-VI),C[C@]12C=CC(=O)C=C1[C@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,train
C[C@]12C=CC(=O)C=C1[C@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,DBMET02853,6βhydroxy-prednisolone(M-VI),DBMET02857,"6β,11β,17α,20α,21-pentahydroxypregnan-1,4-diene-3-one (M-IX)",C[C@]12C=CC(=O)C=C1[C@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)[C@H](O)CO,train
CCCC(CCC)C(=O)O,DB00313,Valproic acid,DBMET00066,(3Z)-2-Propylpent-3-enoic acid (3Z-Ene-VPA),C/C=C\C(CCC)C(=O)O,train
C[C@H]1[C@H](OC(=O)CCC(=O)O)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,DB09274,Artesunate,DBMET00443,Dihydroartemisinin (DHA),C[C@H]1CCC2[C@H](C)[C@H](O)O[C@H]3OC4(C)CC[C@H]1[C@]23OO4,train
CCn1c(C(C)O)nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c1=O,DBMET02171,Etoperidone M2,DBMET02178,Etoperidone M15,CCn1c(C(C)O)nn(CCC(=O)O)c1=O,train
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC,DB00304,Desogestrel,DBMET01366,6-alpha-hydroxydesogestrel,C#C[C@]1(O)CC[C@H]2[C@@H]3C[C@H](O)C4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC,train
C=CC(=O)NC[C@@H](CCC(=O)O)n1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,DBMET02025,PCI-45741 (M25),DBMET02026,M20,C=CC(=O)NC[C@@H](CCC(=O)O)n1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21.[C-3]O,train
CN1C(=O)CCC1c1cccnc1,DBMET00519,Cotinine,DBMET00520,Nornicotine,c1cncc(C2CCCN2)c1,train
CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1,DB01139,Cefapirin,DBMET00641,Desacetylcephapirin,O=C(CSc1ccncc1)NC1C(=O)N2C(C(=O)O)=C(CO)CSC12,train
C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,DB01708,Prasterone,DBMET00599,Dehydroepiandrosterone 3-glucuronide,C[C@]12CC[C@H](O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,train
NNCCc1ccccc1,DB00780,Phenelzine,DB09269,Phenylacetic acid,O=C(O)Cc1ccccc1,train
CNc1c(C)n(C)n(-c2ccccc2)c1=O,DBMET03541,4-methyl-amino-antipyrine (MAA),DBMET03542,4-formyl-amino-antipyrine (FAA),Cc1c(NC=O)c(=O)n(-c2ccccc2)n1C,train
Cc1nc(Cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC#CCO)n(C)c2=O)nc2ccccc12,DBMET02386,Linagliptin M489(1),DBMET02384,Linagliptin M531(1),CC(=O)N[C@@H]1CCCN(c2nc3c(c(=O)n(Cc4nc(C)c5ccccc5n4)c(=O)n3C)n2CC#CCO)C1,train
C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,DB01137,Levofloxacin,DBMET03009,Desmethyl-levofloxacin,C[C@H]1COc2c(N3CCNCC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,train
NC(=O)N1C2=CC3OC3C=C2C=Cc2ccccc21,DBMET00804,"Carbamazepine 2,3-epoxide",DBMET00681,2-hydroxycarbamazepine,NC(=O)N1c2ccccc2C=Cc2cc(O)ccc21,train
Cc1c(=O)n(C)c(Nc2ccc(I)cc2F)c2c(=O)n(C3CC3)c(=O)n(-c3ccc(O)c(N)c3)c12,DBMET03643,Trametinib M3 metabolite,DBMET03644,Trametinib M4 metabolite,Cc1c(=O)n(C)c(Nc2ccc(I)cc2F)c2c(=O)n(C3CC3)c(=O)n(-c3ccc(OC4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)c(N)c3)c12,train
Cc1cccc(C)c1NC(=O)[C@@H]1CCCCN1,DBMET01742,PPX,DBMET03534,4-OH-PPX,Cc1cc(O)cc(C)c1NC(=O)[C@@H]1CCCCN1,train
CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/C(F)(F)COc2ccccc2)[C@H](O)C[C@@H]1O,DB08819,Tafluprost,DBMET00481,Tafluprost free acid,O=C(O)CCC/C=C\CC1C(O)CC(O)C1/C=C/C(F)(F)COc1ccccc1,train
COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1C(=O)OC[n+]1cccc(C(=O)N[C@@H](CO)C(=O)[O-])c1,DB16629,Serdexmethylphenidate,DB06701,Dexmethylphenidate,COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1,train
CNC1(c2ccccc2Cl)CCC(O)CC1=O,DBMET00191,5-Hydroxyketamine,DBMET01309,5-Hydroxynorketamine,NC1(c2ccccc2Cl)CCC(O)CC1=O,train
CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,DB13609,Umifenovir,DBMET03049,Arbidol M6-2 metabolite,CCOC(=O)c1c(CSc2ccc(O)cc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12,train
CCO,DB00898,Ethanol,DBMET00585,Ethyl glucuronide,CCO[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,train
O=C(NCC[N+]1([O-])CCOCC1)c1ccc(Cl)cc1,DBMET02150,Moclobemide M5,DBMET02151,Moclobemide M6,O=C(NCC[N+]1([O-])CCOCC1O)c1ccc(Cl)cc1,train
Cc1c(Cl)cc(O)cc1Nc1ccccc1C(=O)OC1OC(O)C(O)C(O)C1O,DBMET01935,N-(2-methyl-3-chloro-5-hydroxyphenyl)-anthranilic acid form 2,DBMET01936,N-(2-methyl-3-chloro-5-hydroxyphenyl)-anthranilic acid form 3,Cc1c(Cl)cc(OC2OC(O)C(O)C(O)C2O)cc1Nc1ccccc1C(=O)OC1CC(O)C(O)C(O)C1O,train
CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1,DB00982,Isotretinoin,DBMET02548,all-trans-retinoic acid,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,train
COc1ccc2[nH]cc(CCN)c2c1,DBMET01359,5-Methoxytryptamine,DBMET01360,Pinoline,COc1ccc2[nH]c3c(c2c1)CCNC3,train
CCN(CC)C(=O)N1CCN(C)CC1,DB00711,Diethylcarbamazine,DBMET00836,diethylcarbamazine N-oxide,CCN(CC)C(=O)N1CC[N+](C)([O-])CC1,train
CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1,DB12184,Gepirone,DBMET03727,4-OH-methyl-gepirone,CC1(CO)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1,train
CC(S)C(=O)NCC(=O)O,DB06823,Tiopronin,DBMET01416,2-mercaptopropionic acid,CC(S)C(=O)O,train
Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,DB01601,Lopinavir,DBMET03070,Lopinavir M3/M4 metabolite(s),Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCC(O)NC1=O,train
O=C(O)C(=O)C(=O)C(O)C(O)CO,DBMET03075,"2,3-dikeogulonic acid",DBMET00552,Oxalic acid,O=C(O)C(=O)O,train
O=C(O)c1cccnc1,DB00627,Niacin,DBMET02633,N1-methyl-4-pyridone-5-carboxamide,Cn1ccc(=O)c(C(N)=O)c1,train
CC(C)(F)C[C@H](N[C@@H](c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1,DB06670,Odanacatib,DBMET01471,M9 (Odanacatib),CS(=O)(=O)c1ccc(-c2ccc([C@H](O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)C(F)(F)F)cc2)cc1,train
O=C(O)CCC(NC(=O)c1ccccc1C(=O)O)C(=O)O,DBMET01121,2-(o-carboxybenzamido)glutaric acid,DB00142,Glutamic acid,N[C@@H](CCC(=O)O)C(=O)O,train
CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,DB01182,Propafenone,DBMET00932,N-depropylpropafenone,NCC(O)COc1ccccc1C(=O)CCc1ccccc1,train
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,DB00624,Testosterone,DBMET00571,5-alpha-Dihydrotestosterone glucuronide,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)CC[C@@H]12,train
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,DB01060,Amoxicillin,DBMET03002,Amoxicillin M6 Metabolite,CC1(C)CN2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2S1,train
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1,DB00493,Cefotaxime,DBMET00646,Desacetyl-cefotaxime,CO/N=C(\C(O)=N[C@@H]1C(=O)N2C(C(=O)O)=C(CO)CS[C@H]12)c1csc(=N)[nH]1,train
C=CCc1ccccc1OCC(O)CNC(C)C,DB00866,Alprenolol,DBMET00740,4-hydroxy-alprenolol,C=CCc1cc(O)ccc1OCC(O)CNC(C)C,train
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,DB01238,Aripiprazole,DBMET02462,Aripiprazole unnamed metabolite 5,O=C1CCc2ccc(OCCCC[N+]3=CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,train
C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,DB11586,Asunaprevir,DBMET02048,Asunaprevir M8,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)O,train
C[C@H](N)Cc1ccccc1,DB01576,Dextroamphetamine,DBMET02222,Phenylacetone,CC(=O)Cc1ccccc1,train
CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1,DB00998,Frovatriptan,DBMET00921,N-acetyl desmethyl frovatriptan,CC(=O)NC1CCC2Nc3ccc(C(N)=O)cc3C2C1,train
C[S+](CC[C@H](N)C(=O)[O-])C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O,DB00118,Ademetionine,DBMET00486,Cystathionine,N[C@@H](CCSC[C@H](N)C(=O)O)C(=O)O,train
O=C1Cc2cc(CCN3CCN(C4=NS(=O)c5ccccc54)CC3)c(Cl)cc2N1,DBMET02984,Ziprasidone Sulfoxide,DBMET02985,Ziprasidone Sulfone,O=C1Cc2cc(CCN3CCN(C4=NS(=O)(=O)c5ccccc54)CC3)c(Cl)cc2N1,train
CC#CC(=O)NCCCC(=O)c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,DBMET02878,Acalabrutinib M27 Metabolite (ACP-5862),DBMET02880,Acalabrutinib M3 Metabolite,Nc1nccn2c(C(=O)CCC(=O)O)nc(-c3ccc(C(=O)Nc4ccccn4)cc3)c12,train
Nc1ccc(O)cc1,DBMET02710,4- aminophenol,DBMET02711,N-acetyl-4-Aminophenol,CC(O)=Nc1ccc(O)c(C(=O)[C@H](CS)N=C(C)O)c1,train
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,DB00295,Morphine,DBMET02313,Morphine ethereal sulfate,CN1CC[C@]23c4c5ccc(OS(=O)(=O)[O-])c4O[C@H]2[C@@H](OS(=O)(=O)[O-])C=C[C@H]3[C@H]1C5,train
O=C1CCC2=CC(=O)C(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)=CC2N1,DBMET02465,Aripiprazole unnamed metabolite 8,DBMET02466,Aripiprazole unnamed metabolite 9,N[C@@H](CCC(=O)N[C@@H](CSC1=C2CCC(=O)NC2C=C(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)C1O)C(=O)NCC(=O)O)C(=O)O,train
Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1,DBMET03330,Mirabegron M8 metabolite,DBMET03331,Mirabegron M9 metabolite,Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1,train
COC(=O)/C=C/C(=O)OC,DB08908,Dimethyl fumarate,DB14219,Monomethyl fumarate,COC(=O)/C=C/C(=O)O,train
COC(=O)[C@H](c1ccccc1)[C@H]1CCCC(=O)N1,DBMET02408,6-oxo-methylphenidate,DBMET03282,oxo-Ritalinic acid,O=C1CCC[C@H]([C@H](C(=O)O)c2ccccc2)N1,train
CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,DB01420,Testosterone propionate,DB00624,Testosterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,train
CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1,DB09149,Florbetapir F-18,DBMET01427,[18F]AV-267 (N-acetyl–[18F]AV-160),CC(=O)Nc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])nc2)cc1,train
OCc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,DBMET00112,alpha-Hydroxyalprazolam,DBMET02467,"alpha,4-dihydroxy-alprazolam",OCc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2O,train
CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,DB00601,Linezolid,DBMET03355,PNU-142300,CC(=O)NC[C@H]1CN(c2ccc(NCCOCC(=O)O)c(F)c2)C(=O)O1,train
CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,DB00706,Tamsulosin,DBMET02492,Tamsulosin M-2 Metabolite,CCOc1cc(O)ccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,train
Cc1c(Cl)cccc1Nc1ccccc1C(=O)O,DB09216,Tolfenamic acid,DBMET01929,N-(2-methyl-3-chloro-4-hydroxyphenyl)-anthranilic acid,Cc1c(Nc2ccccc2C(=O)OC2OC(O)C(O)C(O)C2O)ccc(O)c1Cl,train
CN(C)Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,DB00546,Adinazolam,DBMET00112,alpha-Hydroxyalprazolam,OCc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,train
CN/C(=N/C#N)NCCSCc1nc[nH]c1C,DB00501,Cimetidine,DBMET03242,cimetidine sulfoxide,CN/C(=N/C#N)NCCSCc1nc[nH]c1C,train
CC#CCn1c(N2CCCC(O)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,DBMET02389,Linagliptin CD1790,DBMET02391,Linagliptin M506(1),CC#CCn1c(NCCCC(O)C(=O)O)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,train
COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,DB00549,Zafirlukast,DBMET01250,Zafirlukast metabolite M1,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(N)cc12,train
N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12,DB00685,Trovafloxacin,DBMET00640,Sulfamate,NS(=O)(=O)O,train
C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,DB08930,Dolutegravir,DBMET01875,defluorinated and gutathione conjugated form of dolutegravir (M4.2),CC1CCOC2Cn3cc(C(=O)NCc4cc(SCC(N)C(=O)O)c(F)cc4O)c(=O)c(O)c3C(=O)N12,train
CC(O)[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,DBMET02478,3'(S)-hydroxy-pravastatin,DBMET02476,3'(S)-hydroxy-pravastatin-tetranor,CC(O)[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CCC(O)O)[C@H]21,train
C1CNCCN1,DB00592,Piperazine,DBMET00950,N-nitroso-3-hydroxypyrrolidine,O=NN1CCC(O)C1,train
CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1,DB08828,Vismodegib,DBMET03663,Vismodegib M14 metabolite,CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2O)c(Cl)c1,train
Nc1ccc(CCNC[C@H](O)c2ccccc2)cc1,DBMET03332,Mirabegron M16 metabolite,DBMET03334,Mirabegron M17 metabolite,Nc1ccc(CCNC[C@H](O)c2ccccc2)cc1,train
CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,DB06700,Desvenlafaxine,DBMET00967,O-Desmethylvenlafaxine glucuronide,NCC(c1ccc(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)cc1)C1(O)CCCCC1,train
Cc1c(=O)n(C)c(Nc2ccc(I)cc2F)c2c(=O)n(C3CC3)c(=O)n(-c3cccc(N)c3)c12,DBMET03641,Trametinib M1 metabolite,DBMET03642,Trametinib M2 metabolite,Cc1c(=O)n(C)c(Nc2ccc(I)cc2F)c2c(=O)n(C3CC3)c(=O)n(-c3cccc(NC4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)c3)c12,train
CC1=C(CC2CO2)C(=O)C[C@@H]1OC(=O)[C@@H]1[C@@H](/C=C(/C)C(=O)O)C1(C)C,DBMET02083,M8 (Bioallethrin),DBMET02084,M9 (Bioallethrin),CC1=C(CC(O)CO)C(=O)C[C@@H]1OC(=O)[C@@H]1[C@@H](/C=C(/C)C(=O)O)C1(C)C,train
CC(C)NCC(O)COc1cccc2[nH]ccc12,DB00960,Pindolol,DBMET03286,Pindolol Glucuronide,CC(C)NCC(COc1cccc2[nH]ccc12)OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,train
Cc1c(Nc2ccccc2C(=O)OC2OC(O)C(O)C(O)C2O)ccc(O)c1Cl,DBMET01929,N-(2-methyl-3-chloro-4-hydroxyphenyl)-anthranilic acid,DBMET01932,N-(2-methyl-3-chloro-4-metoxyphenyl)-anthranilic acid,COc1ccc(Nc2ccccc2C(O)OC2OC(O)C(O)C(O)C2O)c(C)c1Cl,train
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,DB01222,Budesonide,DBMET02912,22-hydroxy Intermediate Metabolite of Budesonide,CCCC1(O)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,train
Cc1onc(-c2ccccc2)c1-c1ccc(S(=O)(=O)NO)cc1,DBMET01338,Valdecoxib metabolite M2,DBMET01342,Valdecoxib metabolite M5,O=S(=O)(NO)c1ccc(-c2c(-c3ccccc3)noc2CO)cc1,train
Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C,DB04817,Metamizole,DBMET03541,4-methyl-amino-antipyrine (MAA),CNc1c(C)n(C)n(-c2ccccc2)c1=O,train
CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21,DB01084,Emedastine,DBMET00752,5-hydroxyemedastine,CCOCCn1c(N2CCCN(C)CC2)nc2cc(O)ccc21,train
O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,DB00537,Ciprofloxacin,DBMET02517,oxociprofloxacin,O=C1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CCN1,train
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@H](O)CC[C@H]3[C@H]1C5,DBMET02684,6-β-hydromorphol,DBMET02725,6-β-hydromorphol glucuronide conjugate 2,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@H](OC2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@H]3[C@H]1C5,train
COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H]2[C@H]2c3c(cc(C)c(OC)c3O)C[C@@H]([C@@H]1O)N2C)OCO4,DB05109,,DBMET01134,Trabectedin metabolite M8b (ET-729),COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H]2[C@@H]2N[C@@H](Cc3cc(C)c(OC)c(O)c32)[C@@H]1O)OCO4,train
COC(=O)C1=C(C)NC(C)=C(C(=O)O)C1c1ccccc1[N+](=O)[O-],DBMET02975,"2,6-dimethyl-4-(2-nitrophenyl)-5-methoxycarbonyl-pyridine-3-carboxylic acid",DBMET02976,2-hydroxymethyl-pyridine carboxylic acid,CC1=C(C(=O)O)CC=CN1,train
Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccc(O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)cc2[nH]1,DBMET03751,5-Glucuronyloxy dexlansoprazole,DBMET03756,5-glucuronyloxy dexlansoprazole sulfide,Cc1c(OCC(F)(F)F)ccnc1CSc1nc2ccc(O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)cc2[nH]1,train
NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,DB00695,Furosemide,DBMET00729,4-chloro-5-sulfamoylanthranilic acid,Nc1cc(Cl)c(S(N)(=O)=O)cc1C(=O)O,train
Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cccc(Cl)c4)cc23)c1F,DBMET01854,vemurafenib intermediary metabolite,DBMET01855,secondary metabolite of vemurafenib,O=Cc1c[nH]c2ncc(-c3ccc(Cl)cc3)cc12,train
C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,DB00248,Cabergoline,DBMET00757,6-allyl-8b-carboxy-ergoline,C=CCN1CC(C(=O)O)C[C@H]2c3cccc4[nH]cc(c34)C[C@@H]21,train
CCN1C(=O)CC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC,DBMET03193,Remoxipride Metabolite FLA 850,DBMET03194,Remoxipride Metabolite NCL 118,COc1ccc(Br)c(OC)c1C(=O)NC[C@@H]1CCC(=O)N1,train
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC,DB00294,Etonogestrel,DBMET02306,Etonogestrel sulfate,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(OS(=O)(=O)C(C)C)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC,train
O=C(O[C@H]1[C@H](OC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@H]1OC(=O)c1cccnc1)c1cccnc1,DB08949,Inositol nicotinate,DBMET01486,Inositol pentanicotinate,O=C(O[C@@H]1[C@@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@H](O)[C@H](OC(=O)c2cccnc2)[C@H]1OC(=O)c1cccnc1)c1cccnc1,train
NC(=O)C(CCC(=O)O)NC(=O)c1ccccc1C(=O)O,DBMET01119,4-(o-carboxybenzamido)glutaramic acid,DB02746,Phthalic Acid,O=C(O)c1ccccc1C(=O)O,train
CCCCC/C=C\C/C=C\CCCCCCCC(=O)O,DB14104,Linoleic acid,DB04557,Arachidonic Acid,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,train
O=C(O)C(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1,DBMET03162,Chloramphenicol Oxamic Acid,DBMET03164,Chloramphenicol Oxamyl Glycine,O=C(O)CNC(=O)C(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1,train
CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,DB00682,Warfarin,DBMET02561,R-Warfarin-R-Alcohol,CC(=O)[C@H](O)[C@H](c1ccccc1)c1c(O)c2ccccc2oc1=O,train
CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,DB00598,Labetalol,DBMET02673,Labetalol 3-hydroxylated Metabolite (VI),CC(CCc1ccccc1)NCC(O)c1cc(O)c(O)c(C(N)=O)c1,train
COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,DB00187,Esmolol,DBMET00536,Methanol,CO,train
Cn1cc[nH]c1=S,DB00763,Methimazole,DBMET02759,Methimazole Epoxide Metabolite,CN1C(S)=NC2OC21,train
CC(=O)O[C@H]1C=C[C@H]2[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3C)[C@H]1O5,DBMET01172,6-Monoacetylmorphine,DBMET00313,morphine,CN1CC[C@]23c4c5ccc(O)c4OC2[C@@H](O)C=CC3C1C5,train
CN1C(S)=NC2OC21,DBMET02759,Methimazole Epoxide Metabolite,DBMET02760,Methimazole Dihydrodiol Metabolite,CN1C(S)=NC(O)C1O,train
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF,DB08906,Fluticasone furoate,DBMET02403,M10 (GW694301X),C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)O,train
CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,DB06781,Difluprednate,DBMET00837,difluoroprednisolone butyrate,CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,train
CC(C)NCC(O)c1cc(O)cc(O)c1,DB00816,Orciprenaline,DBMET00975,Orciprenaline-3-O-sulfate,CC(C)NCC(O)c1cc(O)cc(OS(=O)(=O)O)c1,train
O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,DB00656,Trazodone,DBMET00404,triazolopyridinone epoxide,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2n1C=CC1OC21,train
CCO[C@H]1CCN(Cc2c(OC)cc(C)c3[nH]ccc23)[C@H](c2ccc(C(=O)O)cc2)C1,DB16200,Iptacopan,DBMET03750,M1 iptacopan,CCO[C@H]1CCN[C@H](c2ccc(C(=O)O)cc2)C1,train
OCc1nnc2c3ccccc3cnn12,DBMET02823,3-hydroxy-methyltriazolophthalazine,DBMET02824,Triazolophthalazine,c1ccc2c(c1)cnn1cnnc21,train
O=C(CO)[C@@H](O)[C@@H](O)CO,DB03947,D-Xylulose,DBMET02033,D-Xylulose-5-phosphate,O=C(CO)[C@H](O)[C@@H](O)COP(=O)([O-])[O-],train
CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,DB00953,Rizatriptan,DBMET03668,Rizatriptan N10-oxide,C[N+](C)([O-])CCc1c[nH]c2ccc(Cn3cncn3)cc12,train
C[C@]12C=CC(=O)C=C1[C@@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,DBMET02851,6αhydroxy-prednisolone (M-VII),DBMET02852,"6α,11β,17α,20β,21-pentahydroxypregnan-1,4-diene-3-one (M-X)",C[C@]12C=CC(=O)C=C1[C@@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)[C@@H](O)CO,train
COc1ccccc1OCC(O)COC(N)=O,DB00423,Methocarbamol,DBMET02499,"3-(2-hydroxyphenoxy)-1,2-propanediol-1-carbamate",NC(=O)OCC(O)COc1ccccc1O,train
C[N+]1([O-])CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,DBMET02746,ENB577c,DBMET02747,ENB579b,C[N+]1([O-])CCN(c2ccc(C(O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,train
O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,DB01171,Moclobemide,DBMET02153,Moclobemide M1,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,train
CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(NC)c1ccccc1,DBMET01503,Nortrimebutine,DBMET01504,N-didesmethyltrimebutine,CCC(N)(COC(=O)c1cc(OC)c(OC)c(OC)c1)c1ccccc1,train
C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O,DB00410,Mupirocin,DBMET00912,Monic acid,C/C(=C\C(=O)O)C[C@@H]1CCC(C[C@@H]2O[C@H]2[C@@H](C)C(C)O)[C@@H](O)[C@H]1O,train
C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,DB08865,Crizotinib,DBMET03537,PF-06260182,C[C@@H](Oc1cc(-c2cnn(C3CCNC(=O)C3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,train
O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O,DB00465,Ketorolac,DBMET00978,4-hydroxy ketorolac,O=C(c1ccc(O)cc1)c1ccc2n1CCC2C(=O)O,train
CCc1cc(C(N)=S)ccn1,DB00609,Ethionamide,DBMET00850,Ethionamide sulphoxide,CCc1cc(C(N)=S=O)ccn1,train
CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,DB00433,Prochlorperazine,DBMET02566,Prochlorperazine sulfoxide,CN1CCN(CCCN2c3ccccc3S(=O)c3ccc(Cl)cc32)CC1,train
Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,DB11689,Selumetinib,DBMET03099,M15 (AZ13326637),Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)O)cc21,train
CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,DB00175,Pravastatin,DBMET02472,6-epi-pravastatin,CC[C@H](C)C(=O)O[C@H]1C[C@@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,train
CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O,DB01088,Iloprost,DBMET03767,Dinor-iloprost,CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CC(=O)O)C[C@H]2C[C@H]1O,train
CC(C)(N)Cc1ccccc1,DB00191,Phentermine,DBMET02228,N-hydroxyphentermine,CC(C)(Cc1ccccc1)NO,train
CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2,DB00245,Benzatropine,DBMET02260,N-desmethylbenztropine,c1ccc(C(O[C@H]2C[C@H]3CC[C@@H](C2)N3)c2ccccc2)cc1,train
O=C(O)CCC(C(=O)O)N1C(=O)c2ccccc2C1=O,DBMET01117,2-phthalimidoglutaric acid,DBMET01121,2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)c1ccccc1C(=O)O)C(=O)O,train
Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,DB01254,Dasatinib,DBMET03624,Dasatinib M6 metabolite,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CC(=O)O)CC2)n1,train
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,DB01183,Naloxone,DBMET03369,Naloxone 3-Glucuronide,C=CCN1CC[C@]23c4c5ccc(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,train
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,DB09053,Ibrutinib,DBMET02027,PCI-45752 (M34),C=CC(=O)NC[C@@H](CCCO)n1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,train
CN[C@@H](C)[C@@H](O)c1ccccc1,DB00852,Pseudoephedrine,DBMET02950,Norpseudoephedrine,C[C@H](N)[C@@H](O)c1ccccc1,train
CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,DB00950,Fexofenadine,DBMET02935,MDL 4829 (Azacyclonol),OC(c1ccccc1)(c1ccccc1)C1CCNCC1,train
Cc1c(OCC(F)(F)F)ccnc1C[S@@](=O)c1nc2ccccc2[nH]1,DB05351,Dexlansoprazole,DBMET03755,4-Sulfonyloxy dexlansoprazole,Cc1c(OCC(F)(F)F)ccnc1C[S@@+]([O-])c1nc2c(OS(=O)(=O)O)cccc2[nH]1,train
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21,DB00487,Pefloxacin,DBMET00982,Pefloxacin N-oxide,CC[N+]1([O-])C=C(C(=O)O)C(=O)c2cc(F)c(N3CCN(C)CC3)cc21,train
c1ccc2cnncc2c1,DBMET02816,Phthalazine,DBMET02815,Phthalazinone,O=c1[nH]ncc2ccccc12,train
CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O,DB09570,Ixazomib,DBMET03786,Ixazomib M2 metabolite,NC(=O)CNC(=O)c1cc(Cl)ccc1Cl,train
CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,DB00772,Malathion,DBMET00903,Malathion monocarboxylic acid,CCOC(=O)C(CC(=O)O)SP(=S)(OC)OC,train
CC[C@@H](CO)NCCN[C@@H](CC)CO,DB00330,Ethambutol,DBMET03256,Ethambutol Aldehyde,CC[C@@H](CO)NCCN[C@@H](CC)CO,train
CN1CCC[C@H]1c1cccnc1,DB00184,Nicotine,DBMET00515,N-Methylnicotinium,CN1CCCC1c1ccc[n+](C)c1,train
NC(=O)CNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,DBMET03715,Momelotinib M15 metabolite,DBMET03712,Momelotinib M8 metabolite,NC(=O)CNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4=O)cc3)n2)cc1,train
C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1,DB00922,Levosimendan,DBMET00974,OR-1896,CC(=O)Nc1ccc(C2=NNC(=O)C[C@H]2C)cc1,train
Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1,DB01067,Glipizide,DBMET00205,3-cis-Hydroxyglipizide,Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCC[C@@H](O)C3)cc2)cn1,train
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1,DB08815,Lurasidone,DBMET00890,ID11614,c1ccc2c(N3CCNCC3)nsc2c1,train
CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](NC)[C@H]2O)[C@](C)(OCC=Cc2cnc3ccccc3c2)C[C@@H](C)C(=O)[C@H](C)[C@H]2NC(=O)O[C@@]21C,DBMET03134,N-desmethyl cethromycin,DBMET03135,"N,N-didesmethyl cethromycin",CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N)[C@H]2O)[C@](C)(OCC=Cc2cnc3ccccc3c2)C[C@@H](C)C(=O)[C@H](C)[C@H]2NC(=O)O[C@@]21C,train
Nc1nc(=O)c2ncn(COCCO)c2[nH]1,DB00787,Acyclovir,DBMET00782,9-carboxymethoxymethylguanine,N=c1nc(O)c2ncn(COCC(=O)O)c2[nH]1,train
O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O,DB00186,Lorazepam,DBMET00648,Lorazepam glucuronide,O=C(O)[C@H]1O[C@@H](OC2N=C(c3ccccc3Cl)c3cc(Cl)ccc3N=C2O)[C@H](O)[C@@H](O)[C@@H]1O,train
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl,DB14512,Mometasone furoate,DBMET02362,"21-chloro-17-alpha-hydroxy-16-alpha-methyl-9-beta,11beta-oxidopregna-1,4-diene-3,20-dione 17-(2-furoate)",C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]34O[C@H]4C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl,train
O=S(=O)(O)CCS,DB09110,Coenzyme M,DBMET01434,dimesna,O=S(=O)(O)CCSSCCS(=O)(=O)O,train
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,DB00755,Tretinoin,DBMET03634,Retinotaurine,CC1=C(/C=C/C(C)=C/CCC(C)C(=O)NCCS(=O)(=O)O)C(C)(CO)CCC1=O,train
COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1,DB06701,Dexmethylphenidate,DBMET02407,p-hydroxy-methylphenidate,COC(=O)[C@H](c1ccc(O)cc1)[C@H]1CCCCN1,train
O=C(OC1OC(O)C(O)C(O)C1O)c1ccccc1Nc1cccc(Cl)c1CO,DBMET01937,N-(2-hydroxymethyl-3-chlorophenyl)-anthranilic acid,DBMET01938,N-(2-formyl-3-chlorophenyl) anthranilic acid,O=Cc1c(Cl)cccc1Nc1ccccc1C(=O)OC1OC(O)C(O)C(O)C1O,train
Oc1ccc([C@@H](O)c2ccc(Cl)cc2)cc1,DBMET02646,Levocetirizine N-dealkylated and Aromatic Hydroxylated Metabolite (M9),DBMET02649,Levocetirizine 4-chloro-4'-hydroxybenzhydryl Mercapturate Metabolites (M10a and M10b),CC(=O)NC(CS[C@H](c1ccc(O)cc1)c1ccc(Cl)cc1)C(=O)O,train
Cn1c(C(=O)O)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DBMET03382,Dabigatran M369,DBMET03383,Dabigatran M325,Cn1cnc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,train
Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1,DB01241,Gemfibrozil,DBMET02786,Gemfibrozil M2 Metabolite,Cc1cc(OCCCC(C)(C)C(=O)O)c(C)cc1O,train
Cn1nnc2c(C(N)=O)ncn2c1=O,DB00853,Temozolomide,DBMET03267,5-(3-methyltriazen-1-yl) imidazole-4-carboxamide (MTIC),Cn1nnc2c(C(N)=O)ncn2c1=O,train
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,DB05294,Vandetanib,DBMET00935,N-desmethyl vandetanib,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCNCC1,train
COc1c(O)ccc(CN2CCNCC2)c1OC,DBMET03345,4-desmethyltrimetazidine,DBMET03351,4-desmethyltrimetazidine O-sulphate,COc1c(CN2CCNCC2)ccc(OS(=O)(=O)[O-])c1OC,train
COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1,DB00983,Formoterol,DBMET02961,Formoterol deformylated metabolite,COc1ccc(CC(C)NCC(O)c2ccc(O)c(N)c2)cc1,train
CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,DB00412,Rosiglitazone,DBMET01365,Phenoxyacetic acid derivative of rosiglitazone,O=C(O)COc1ccc(CC2SC(=O)NC2=O)cc1,train
CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,DB11363,Alectinib,DBMET02147,M1b (Alectinib),CCc1cc2c(cc1N1CCC(N(CCO)CC(=O)O)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,train
Cn1c(C(=O)Nc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DBMET03381,Dabigatran M486,DBMET03382,Dabigatran M369,Cn1c(C(=O)O)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,train
CCOc1ccc(C(=O)C2NCCc3cc(OCC)c(OCC)cc32)cc1OCC,DBMET03305,Drotaveraldine,DBMET03304,4'-desethyl-drotaveraldine,CCOc1cc2c(cc1O)CCNC2C(=O)c1ccc(OCC)c(OCC)c1,train
COC(=O)/C=C/C(=O)O,DB14219,Monomethyl fumarate,DB01677,Fumaric acid,O=C(O)/C=C/C(=O)O,train
O=[N+]([O-])C(Br)CO,DBMET02073,Bromonitroethanol,DBMET02074,Bromonitromethane,O=[N+]([O-])CBr,train
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC,DBMET03015,17-desacetylnorgestimate,DB09389,Norgestrel,C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21CC,train
C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN,DB01255,Lisdexamfetamine,DB01576,Dextroamphetamine,C[C@H](N)Cc1ccccc1,train
CN1c2c(oc(=O)n(-c3ccccn3)c2=O)-c2ccccc2S1(=O)=O,DB09215,Droxicam,DB00554,Piroxicam,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,train
CC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1,DBMET03158,Chloramphenicol 3-acetate,DBMET03159,Chloramphenicol 1-acetate,CC(=O)O[C@H](c1ccc([N+](=O)[O-])cc1)[C@@H](CO)NC(=O)C(Cl)Cl,train
C[C@]12C=CC(=O)CC1[C@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)[C@H](O)CO,DBMET02858,"6β,11β,17α,20α,21-pentahydroxy-5ξ-pregn-1-en-3-one (M-XVI)",DBMET02856,"6β,11β,17α,21-tetrahydroxy-5ξ-pregn-1-en-3,20-dione (M-XIV)",C[C@]12C=CC(=O)CC1[C@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,train
O=[Se](O)O,DB11127,Selenious acid,DBMET01468,Selenodiglutathione,N[C@@H](CCC(=O)N[C@@H](CS[Se]SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O,train
COC1=C(OC)C(=O)C(CCCCCCO)=C(C)C1=O,DBMET01523,QS6,DBMET01524,QS4,COC1=C(OC)C(=O)C(CCCCO)=C(C)C1=O,train
Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1,DB00500,Tolmetin,DBMET00652,Tolmetin glucuronide,Cc1ccc(C(=O)c2ccc(CC(=O)O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)n2C)cc1,train
Cn1c(CO)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DBMET03384,Dabigatran M355,DBMET03382,Dabigatran M369,Cn1c(C(=O)O)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,train
CC(C)n1c(=O)cc(N[C@@H](C)c2ccccc2)[nH]c1=O,DB14921,Mavacamten,DBMET03496,MYK-2210,CC(C)n1c(=O)cc(N[C@@H](C)c2ccc(O)cc2)[nH]c1=O,train
O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO,DB11735,Galactose,DBMET02088,α-D-galactose,OCC1O[C@H](O)[C@H](O)C(O)C1O,train
Nc1nc(=O)c2c([nH]1)N[C@@H]1O[C@@H]3COP(=O)(O)O[C@@H]3C(O)(O)[C@@H]1N2,DB16628,Fosdenopterin,DBMET03277,Compound Z,N=c1nc(O)c2nc(C(=O)[C@@H]3OP(=O)(O)OC[C@@H]3O)cnc2[nH]1,train
OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,DB00875,Flupentixol,DBMET03259,Flupentixol glucuronide,O=C(OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1)C1OC(O)[C@@H](O)[C@H](O)[C@H]1O,train
O=C([O-])c1ccccc1,DBMET01436,Benzoyloxyl radical,DBMET03364,Phenyl Radical,[C+]1=CC=CC=C1,train
Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,DB01015,Sulfamethoxazole,DBMET03017,Sulfamethoxazole N-glucuronide,Cc1cc(NS(=O)(=O)c2ccc(NOC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)cc2)no1,train
Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)O)ccc21,DBMET03379,BIBR1151/M324,DBMET03380,Dabigatran M500,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)OC3O[C@@H](C(=O)O)[C@H](O)[C@@H](O)[C@@H]3O)ccc21,train
[O-][n+]1ccc(N2CCN(CCCN3CCN(c4ccnc5cc(Cl)ccc45)CC3)CC2)c2ccc(Cl)cc21,DBMET01947,M2 (piperaquine),DBMET01948,M5 (piperaquine),[O-][n+]1ccc(N2CCN(CCCN3CCN(c4cc[n+]([O-])c5cc(Cl)ccc45)CC3)CC2)c2ccc(Cl)cc21,train
COc1ccsc1CNCC[C@@]1(c2ccccn2)CCO[C@]2(CCC(O)C2)C1,DBMET03206,Oxy-oliceridine,DBMET03207,TRV0306954,COc1ccsc1CNCC[C@@]1(c2ccccn2)CCO[C@]2(CC[C@H](OC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)C2)C1,train
COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314,DB00956,Hydrocodone,DBMET02687,6-β-hydrocodol,COc1ccc2c3c1O[C@H]1[C@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341,train
CNS(=O)(=O)Cc1ccc2[nH]cc(CC(=O)O)c2c1,DBMET02583,Sumatriptan Metabolite GR49336,DBMET02584,Sumatriptan Metabolite Ester Glucuronide of GR49336,CNS(=O)(=O)Cc1ccc2[nH]cc(CC(=O)OC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)c2c1,train
CCCN(C)C(CC)[C@@H]1C=C[C@H](O)[C@@H]2Oc3c(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O)[C@H]4O)cccc3[C@H]21.O=CO,DBMET00462,morphine-3-glucuronide,DBMET02018,"morphine-3,6-diglucuronide",OC1OC(Oc2ccc3c4c2OC2C(OC5OC(O)C(O)C(O)C5O)C=CC5C(C3)NCC[C@@]452)C(O)C(O)C1O,train
CNNCc1ccc(C(=O)NC(C)C)cc1,DB01168,Procarbazine,DBMET00617,Hydrazine,NN,train
O[As](O)O,DB04456,Arsenous acid,DBMET02875,Dimethylarsinic acid,C[As](C)(=O)O,train
Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1,DB00369,Cidofovir,DBMET03373,Cidofovir diphosphate,Nc1ccn(C[C@@H](CO)OCP(=O)(O)OP(=O)(O)O)c(=O)n1,train
CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)[C@H](CO)c1ccccc1)C2,DB00424,Hyoscyamine,DBMET03252,Tropine,CN1[C@@H]2CC[C@H]1C[C@@H](O)C2,train
COc1ccc(Oc2cc(N(C)CCOc3ccc(CC4SC(=O)NC4=O)cc3)ncn2)cc1,DB09198,Lobeglitazone,DBMET01518,M2,COc1ccc(Oc2cc(NCCOc3ccc(CC4SC(=O)NC4=O)cc3)ncn2)cc1,train
O=S1N=C(N2CCNCC2)c2ccccc21,DBMET02990,"3-(piperazine-1-yl)-1,2-benzisothiazole sulfoxide",DBMET02991,"3-(piperazine-1-yl)-1,2-benzisothiazole sulfone",O=S1(=O)N=C(N2CCNCC2)c2ccccc21,train
CN(C)CCCN1c2ccccc2CCc2ccccc21,DB00458,Imipramine,DBMET01957,Imipramine N-oxide,C[N+](C)([O-])CCCN1c2ccccc2CCc2ccccc21,train
CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,DB00905,Bimatoprost,DBMET02588,17-Phenyl-Trinor-PGF2alpha,O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O,train
Oc1ccc(O)cc1,DB09526,Hydroquinone,DBMET02101,hydroquinone sulfate,O=S(=O)(O)Oc1ccc(O)cc1,train
C[C@]12C=CC(=O)C=C1[C@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)[C@@H](O)CO,DBMET02854,"6β,11β,17α,20β,21-pentahydroxypregnan-1,4-diene-3-one (M-VIII)",DBMET02855,"6β,11β,17α,20β,21-pentahydroxy-5ξ-pregn-1-en-3-one (M-XV)",C[C@]12C=CC(=O)CC1[C@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)[C@@H](O)CO,train
CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1,DB11855,Revefenacin,DBMET02191,THRX-195518,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(=O)O)CC2)cc1,train
COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,DB00457,Prazosin,DBMET00691,"2,4-diamino-6,7-dimethoxyquinazoline",COc1cc2nc(N)nc(N)c2cc1OC,train
CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c(C(N)=O)c1,DBMET02671,Labetalol Hydroxylated Metabolite (IV),DBMET02672,Labetalol Phenolic Glucuronide Metabolite (V),CC(CCc1ccc(OC2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)cc1)NCC(O)c1ccc(O)c(C(N)=O)c1,train
CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN,DB08918,Levomilnacipran,DBMET03703,p-Hydroxy-levomilnacipran,CCN(CC)C(=O)[C@@]1(c2ccc(O)cc2)C[C@H]1CN,train
N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,DB00279,Liothyronine,DBMET02273,Diiodothyronine,N[C@@H](Cc1cc(I)c(Oc2ccc(O)cc2)c(I)c1)C(=O)O,train
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O,DB13169,Nandrolone,DBMET03360,19-Norepiandrosterone,C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@@H]43)[C@@H]1CCC2=O,train
C[C@H](N[P@](=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)Oc1ccccc1)C(=O)[O-],DBMET03214,,DBMET03215,Remdesivir cyclic anhydride,C[C@@H]1NP(=O)(OC[C@H]2O[C@@](C#N)(c3ccc4c(N)ncnn34)[C@H](O)[C@@H]2O)OC1=O,train
CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,DB13944,Testosterone enanthate,DB00624,Testosterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,train
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DB00813,Fentanyl,DBMET02568,Despropionylfentanyl,c1ccc(CCN2CCC(Nc3ccccc3)CC2)cc1,train
O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,DB01041,Thalidomide,DBMET01118,alpha-(o-carboxybenzamido)glutarimide,O=C1CCC(NC(=O)c2ccccc2C(=O)O)C(=O)N1,train
COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,DB01280,Nelarabine,DBMET03666,6-O-methylguanine,COc1nc(N)nc2[nH]cnc12,train
CC(O)CCc1ccc2cc(O)ccc2c1,DBMET02537,4-(6-hydroxy-2-naphthyl)- butan-2-ol,DBMET02538,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (6-OH conjugated),CC(O)CCc1ccc2cc(OC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)ccc2c1,train
CN(C)CCCN1c2ccccc2Sc2ccccc21,DB00420,Promazine,DBMET01213,3-Hydroxypromazine,CN(C)CCCN1c2ccccc2Sc2cc(O)ccc21,train
C/C(=N\Nc1nncc2ccccc12)C(=O)O,DBMET00864,Hydralazine pyruvate hydrazone,DBMET02814,Hydralazine pyruvate hydrazone tricyclic dehydration product,Cc1nnc2c3ccccc3cnn2c1=O,train
CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O,DB02912,Propanoyl-CoA,DB04045,(R)-methylmalonyl-CoA,C[C@H](C(=O)O)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O,train
Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)OC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)c3ccccn3)ccc21,DBMET02413,Dabigatran 1-O-acylglucuronide metabolite,DBMET02415,Dabigatran 3-O-acylglucuronide metabolite,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)OC3[C@@H](O)C(O)O[C@H](C(=O)O)[C@H]3O)c3ccccn3)ccc21,train
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O,DB00881,Quinapril,DBMET02775,Quinapril Metabolite PD109488,CCOC(=O)[C@H](CCc1ccccc1)N1C(=O)C2Cc3ccccc3CN2C(=O)C1C,train
CC(C)(C(=O)c1cccnc1)c1cccnc1,DB01011,Metyrapone,DBMET00909,Metyrapol,CC(C)(c1cccnc1)C(O)c1cccnc1,train
Cc1nnc2c3ccccc3cnn2c1=O,DBMET02814,Hydralazine pyruvate hydrazone tricyclic dehydration product,DBMET00864,Hydralazine pyruvate hydrazone,C/C(=N\Nc1nncc2ccccc12)C(=O)O,train
CCCC1(O)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,DBMET02912,,DBMET02913,16alpha-butyrloxyprednisolone,CCCC(=O)O[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,train
O=S(=O)(O)Oc1ccc(C(c2ccc(OS(=O)(=O)O)cc2)c2ccccn2)cc1,DB09268,Picosulfuric acid,DBMET03353,Bis-(p-hydroxyphenyl)-pyridyl-2-methane,Oc1ccc(C(c2ccc(O)cc2)c2ccccn2)cc1,train
CC(=O)NNc1nncc2ccccc12,DBMET02820,Unnamed hydralazine metabolite,DBMET02821,3-methyl-s-triazolophthalazine,Cc1nnc2c3ccccc3cnn12,train
CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,DB01053,Benzylpenicillin,DBMET00983,Penicilloic acid,CC1(C)SC(C(NC(=O)Cc2ccccc2)C(=O)O)NC1C(=O)O,train
O=C(CCO)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DBMET02569,Hydroxyfentanyl,DBMET02570,Hydroxynorfentanyl,O=C(CCO)N(c1ccccc1)C1CCNCC1,train
CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,DB11677,Triheptanoin,DBMET03172,Heptanoate,CCCCCCC(=O)[O-],train
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,DB01586,Ursodeoxycholic acid,DBMET03599,7-oxo-lithocholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,train
CC(=O)NCCNc1ccc(OCC2COC(Cn3ccnc3)(c3ccc(Cl)cc3Cl)O2)cc1,DBMET02658,M10 (Ketoconazole),DBMET02659,M15 (Ketoconazole),Nc1ccc(OCC2COC(Cn3ccnc3)(c3ccc(Cl)cc3Cl)O2)cc1,train
NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CN)C(=O)O,DB11296,Prezatide,DBMET01483,Histidyl-lysine,NCCCC[C@H](N=C(O)[C@@H](N)Cc1cnc[nH]1)C(=O)O,train
Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,DB00480,Lenalidomide,DBMET03254,5­-Hydroxy-lenalidomide,Nc1c(O)ccc2c1CN(C1CCC(=O)NC1=O)C2=O,train
C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,DB13953,Estradiol benzoate,DB00783,Estradiol,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,train
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1CO,DBMET02124,N-hydroxymethyl-aripiprazole,DB01238,Aripiprazole,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,train
O=C(O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,DBMET03713,Momelotinib M19 metabolite,DBMET03711,Momelotinib M14 metabolite,O=C(O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4=O)cc3)n2)cc1,train
C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O,DB06176,Romidepsin,DBMET01414,Romidepsin (active),CC=C1N=C(O)[C@@H](CS)N=C(O)[C@@H](C(C)C)CC(=O)C[C@@H](/C=C/CCS)OC(=O)[C@H](C(C)C)N=C1O,train
CCCC[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12,DB09300,Butylscopolamine,DBMET01509,BA 790 Br (Scopolamine Butylbromide),C=C(Cc1ccccc1)C(=O)OC1CC2C3OC3C(C1)[N+]2(C)CCCC.[Br-],train
OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O,DB00938,Salmeterol,DBMET02979,Salmeterol O-dealkylated Metabolite,O=C(O)CCCCCNCC(O)c1ccc(O)c(CO)c1,train
CCn1c(=O)c2c(nc(/C=C/c3ccc(OC)c(OC)c3)n2C)n(CC)c1=O,DB11757,Istradefylline,DBMET02755,1-β-hydroxylated Istradefylline (M8),CCn1c(=O)n(CCO)c(=O)c2c1nc(/C=C/c1ccc(OC)c(OC)c1)n2C,train
CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,DB06292,Dapagliflozin,DBMET02424,"Dapagliflozin BMS-511926, M8 metabolite",OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,train
C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC5CCCC5)ccc4[C@H]3CC[C@@]21C,DB04575,Quinestrol,DB00977,Ethinylestradiol,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,train
CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,DB00796,Candesartan cilexetil,DB13919,Candesartan,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,train
CCOc1cc(O)ccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,DBMET02492,Tamsulosin M-2 Metabolite,DBMET02493,Tamsulosin M-2-Glu Metabolite,CCOc1cc(OC2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)ccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,train
CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)=O)cc1,DB00605,Sulindac,DBMET01002,Sulindac sulfide,CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1,train
COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1,DB14881,Oliceridine,DBMET03206,Oxy-oliceridine,COc1ccsc1CNCC[C@@]1(c2ccccn2)CCO[C@]2(CCC(O)C2)C1,train
COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,DB13783,Acemetacin,DBMET01881,des-4-chlorobenzoyl-indomethacin,COc1ccc2[nH]c(C)c(CC(=O)O)c2c1,train
O=C(O)[C@@H](Nc1cncc(F)c1)c1ccccc1Cl,DBMET03503,Ivosidenib M39 metabolite,DBMET03504,Ivosidenib M37 metabolite,O=C(O)[C@H](c1ccccc1Cl)N(O)c1cncc(F)c1,train
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1,DB13954,Estradiol cypionate,DB00783,Estradiol,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,train
O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1,DB06282,Levocetirizine,DBMET02642,Levocetirizine N-oxide Metabolite (M3),O=C(O)COCC[N+]1(O)CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1,train
CCC1(c2ccccc2)C(=O)NCNC1=O,DB00794,Primidone,DBMET02951,Phenylethylmalonamide (PEMA),CCC(C(N)=O)(C(N)=O)c1ccccc1,train
O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,DB00698,Nitrofurantoin,DBMET00798,Aminofurantoin,Nc1ccc(C=NN2CC(O)=NC2=O)o1,train
C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,DB00968,Methyldopa,DBMET00637,"3,4-Dihydroxyphenylacetone",CC(=O)Cc1ccc(O)c(O)c1,train
C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F,DB06207,Silodosin,DBMET03298,KMD-3289,C[C@H](Cc1cc2c(c(C(N)=O)c1)NCC2)NCCOc1ccccc1OCC(F)(F)F,train
CC(N)Cc1ccc(O)cc1,DBMET00733,4-hydroxyamphetamine,DBMET01018,4-Hydroxynorephedrine,C[C@@H](N)[C@@H](O)c1ccc(O)cc1,train
O=Cc1c(Cl)cccc1Nc1ccccc1C(=O)OC1OC(O)C(O)C(O)C1O,DBMET01938,N-(2-formyl-3-chlorophenyl) anthranilic acid,DBMET01941,N-(2-carboxy-3-chlorophenyl)-anthranilic acid,O=C(OC1OC(O)C(O)C(O)C1O)c1ccccc1Nc1cccc(Cl)c1C(=O)O,train
Cc1nnc2c3ccccc3cnn12,DBMET02821,3-methyl-s-triazolophthalazine,DBMET02823,3-hydroxy-methyltriazolophthalazine,OCc1nnc2c3ccccc3cnn12,train
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1.[C-3]O,DBMET02023,PCI-45773 (M35),DBMET02024,M17,C=CC(=O)NC[C@@H](CCCO)n1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21.[C-3]O,train
CC1(C=O)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,DBMET03000,Amoxicillin M4 Metabolite,DBMET03001,Amoxicillin M5 Metabolite,CC1(C(=O)O)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,train
O=C(CO)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1,DBMET03161,Chloramphenicol Alcohol,DBMET03162,Chloramphenicol Oxamic Acid,O=C(O)C(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1,train
C[NH+]1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1O,DBMET02745,ENB577b,DBMET02749,ENB753,C[NH+]1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,train
C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,DB00741,Hydrocortisone,DBMET02907,Tetrahydrocortisone Glucuronide 2,C[C@]12CCC(OC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)CC1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,train
CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,DB00231,Temazepam,DBMET00650,Oxazepam glucuronide,O=C(O)[C@H]1O[C@@H](OC2N=C(c3ccccc3)c3cc(Cl)ccc3N=C2O)[C@H](O)[C@@H](O)[C@@H]1O,train
Nc1ccc(C(=O)O)cc1,DB02362,Aminobenzoic acid,DBMET03290,4-Acetaminobenzoic acid,CC(=O)Nc1ccc(C(=O)O)cc1,train
CC(C)[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2,DB00332,Ipratropium,DBMET02396,N-isopropylnortropium bromide,CC(C)[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)Cc1ccccc1)C2,train
CCC(CO)(c1ccccc1)N(C)C,DBMET01505,2-dimethylamino-2-phenylbutan-1-ol,DBMET01506,2-methylamino-2-phenylbutan-1-ol ,CCC(CO)(NC)c1ccccc1,train
CCOc1ccc(C[C@@H](NC(=O)CCS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)O)[C@@H](C)CC)cc1,DBMET02065,Reduced Metabolite (Atosiban),DBMET02067,Small Fragment Metabolite (Atosiban),NCCC[C@H](N)C(=O)NCC(N)=O,train
COc1ccccc1OCC(O)CO,DB00874,Guaifenesin,DBMET00802,beta-(2-methoxyphenoxy)-lactic acid,COc1ccccc1OCC(O)C(=O)O,train
CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C,DB13956,Estradiol valerate,DB00783,Estradiol,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,train
O=C(O)c1ccccc1,DB03793,Benzoic acid,DBMET00584,Benzoyl glucuronide (Benzoic acid),O=C(O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1,train
CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC1,DB00523,Alitretinoin,DBMET03638,9-cis-4-Oxoretinoic acid,CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC1=O,train
Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DB14726,Dabigatran,DBMET03379,BIBR1151/M324,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)O)ccc21,train
C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]34O[C@H]4C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl,DBMET02362,"21-chloro-17-alpha-hydroxy-16-alpha-methyl-9-beta,11beta-oxidopregna-1,4-diene-3,20-dione 17-(2-furoate)",DBMET02367,"21-chloro-17-alpha-hydroxy-16-alpha-methyl-9-beta,11-beta-oxidopregna-1,4-diene-3,20-dione",C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]34O[C@H]4CC2(C)[C@@]1(O)C(=O)CCl,train
CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O,DBMET03175,Acetyl Coenzyme A,DBMET03176,Propionyl Coenzyme A,CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O,train
CC(=O)N1CCN(c2ccc(OCC3COC(CN4C=NC5OC54)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DBMET02660,Ketoconazole epoxide intermediate,DBMET02665,Ketoconazole dihydroxyl intermediate,CC(=O)N1CCN(c2ccc(OCC3COC(CN4C=NC(O)C4O)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,train
[OH2+][Pt]1(Cl)N[C@@H]2CCCC[C@H]2N1,DBMET03684,Monoaquo DACH platinum,DBMET03685,Diaquo DACH platinum,[OH2+][Pt]1([OH2+])N[C@@H]2CCCC[C@H]2N1,train
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,DB00188,Bortezomib,DBMET01081,Bortezomib metabolite M34,CC(C)CC(=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1,train
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC,DB08887,Icosapent ethyl,DBMET00546,EPA,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,train
O=C(O)N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,DBMET02432,Sitagliptin Unnamed Metabolite,DBMET02433,Sitagliptin M4 Metabolite,O=C(N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F)OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,train
N=c1nc(O)n([C@@H]2CS[C@H](CO)O2)cc1F,DB00879,Emtricitabine,DBMET02870,Emtricitabine O-glucuronide (M-II),Nc1nc(=O)n([C@@H]2CS[C@H](COC3OC(C(O)O)C(O)C(O)C3O)O2)cc1F,train
O=C(O)Cc1ccccc1,DB09269,Phenylacetic acid,DBMET01954,4-hydroxyphenylacetic acid,O=C(O)Cc1ccc(O)cc1,train
Cn1c(CCCC(=O)O)nc2cc(N(CCO)CCCl)ccc21,DBMET01423,monohydroxy-bendamustine (bendamustine metabolite HP1),DBMET01424,dihydroxy-bendamustine (bendamustine metabolite HP2),Cn1c(CCCC(=O)O)nc2cc(N(CCO)CCO)ccc21,train
O=C(O[C@H]1[C@H](OC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@@H](O)[C@@H](O)[C@@H]1OC(=O)c1cccnc1)c1cccnc1,DBMET01487,Inositol tetranicotinate,DBMET01488,Inositol trinicotinate,O=C(O[C@H]1[C@H](OC(=O)c2cccnc2)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1OC(=O)c1cccnc1)c1cccnc1,train
Nc1ccc(C(=O)O)c(Cl)c1,DBMET03556,2-chloro-p-aminobenzoic acid,DBMET03557,N-acetyl-2-chloro-p-aminobenzoic acid,CC(=O)Nc1ccc(C(=O)O)c(Cl)c1,train
CCOC(=O)c1ccc(N)cc1,DB01086,Benzocaine,DB02362,Aminobenzoic acid,Nc1ccc(C(=O)O)cc1,train
CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1,DB16217,Leniolisib,DBMET03657,Leniolisib M1 metabolite,CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(O)c(C(F)(F)F)c2)CC3)C1,train
CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,DB01242,Clomipramine,DBMET00817,clomipramine N-oxide,C[N+](C)([O-])CCCN1c2ccccc2CCc2ccc(Cl)cc21,train
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O,DB14669,Betamethasone phosphate,DB00443,Betamethasone,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,train
CC(C)N(O)CC(O)COc1cccc2[nH]ccc12,DBMET03287,3-Hydroxy Pindolol,DBMET03289,Pindolol 3-glucuronide,CC(C)N(CC(O)COc1cccc2[nH]ccc12)OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,train
COC(=O)c1c(C)nc(C)c(C(=O)OCC(C)O)c1-c1ccccc1[N+](=O)[O-],DBMET01951,Aranidipine M-4,DBMET01953,Aranidipine M-5,COC(=O)c1c(C)nc(C)c(C(=O)O)c1-c1ccccc1[N+](=O)[O-],train
O=[N+]([O-])C(Br)(CO)CO,DB13960,Bronopol,DBMET02073,Bromonitroethanol,O=[N+]([O-])C(Br)CO,train
COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1,DB00243,Ranolazine,DBMET02247,CVT-2513,Cc1cccc(C)c1NC(=O)CN1CCNCC1,train
COC(=O)c1cccnc1,DB13882,Methyl nicotinate,DB00627,Niacin,O=C(O)c1cccnc1,train
CC[C@@H](C(N)=O)N1CCCC1=O,DB01202,Levetiracetam,DBMET02789,Levetiracetam carboxylic acid metabolite (L057),CC[C@@H](C(=O)O)N1CCCC1=O,train
CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,DB00690,Flurazepam,DBMET00882,Hydroxyethylflurazepam,CCN(CCO)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,train
NCCCN1c2ccccc2CCc2ccccc21,DBMET01959,Didemethylimipramine,DBMET01961,10-hydroxydidemethylimipramine,NCCCN1c2ccccc2CC(O)c2ccccc21,train
COc1ccc2c3c1O[C@H]1C[C@H](O)C=C[C@@]31CCN(C)C2,DBMET03150,Epigalantamine,DBMET03153,Sulfate conjugate of epigalantamine,COc1ccc2c3c1O[C@H]1C[C@H](OS(=O)(=O)O)C=C[C@@]31CCN(C)C2,train
CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O,DB02703,Fusidic acid,DBMET00715,3-keto fusidic acid,CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(/C(=O)O)C(=O)CC=C(C)C,train
CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,DB00669,Sumatriptan,DBMET02583,Sumatriptan Metabolite GR49336,CNS(=O)(=O)Cc1ccc2[nH]cc(CC(=O)O)c2c1,train
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,DB11753,Rifamycin,DBMET02189,25-deacetyl-rifamycin,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](O)[C@@H]1C,train
CCN(CC)C(=O)C1(c2ccccc2)CC1CN,DB04896,Milnacipran,DBMET02300,Milnacipran carbamic acid,CCN(CC)C(=O)C1(c2ccccc2)CC1CNC(=O)O,train
COc1ccc(CC(C)NCC(O)c2ccc(O)c(N)c2)cc1,DBMET02961,Formoterol deformylated metabolite,DBMET02962,Deformylated formoterol metabolite sulfate conjugate,COc1ccc(CC(C)NCC(O)c2ccc(OS(=O)(=O)[O-])c([NH3+])c2)cc1,train
Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1,DB00891,Sulfapyridine,DBMET03575,5'-hydroxysulfapyridine,Nc1ccc(S(=O)(=O)Nc2ccc(O)cn2)cc1,train
Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,DB00814,Meloxicam,DBMET00755,5'-hydroxymethyl meloxicam,CN1C(C(O)=Nc2ncc(CO)s2)=C(O)c2ccccc2S1(=O)=O,train
NC(=O)CCC(C(=O)O)N1C(=O)c2ccccc2C1=O,DBMET01116,2-phthalimidoglutaramic acid,DBMET01117,2-phthalimidoglutaric acid,O=C(O)CCC(C(=O)O)N1C(=O)c2ccccc2C1=O,train
C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12,DB00959,Methylprednisolone,DBMET02923,Methylprednisolone M7 Metabolite,C[C@]12C=CC(=O)C=C1[C@](C)(O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,train
CC#CCn1c(N2CCCC(=O)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,DBMET02388,Linagliptin CD10604,DBMET02389,Linagliptin CD1790,CC#CCn1c(N2CCCC(O)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,train
O=BOO,DB13235,Perboric acid,DBMET02108,Carbonate,O=C([O-])[O-],train
CCCC[N+]1(C)C2CC(O)CC1C1OC12.[Br-],DBMET01508,BA 345 Br (Scopolamine Butylbromide),DBMET01510,AD12 (Scopolamine Butylbromide),CCCC[N+]1(C)C2CC3CC1C(O3)C2O.[Br-],train
COc1ccc2cc(CCC(C)O)ccc2c1,DBMET02535,4-(6-Methoxy-2-naphthyl)- butan-2-ol,DBMET02536,4-(6-Methoxy-2-naphthyl)- butan-2-ol glucuronide,COc1ccc2cc(CCC(C)OC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)ccc2c1,train
C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,DB01012,Cinacalcet,DBMET00510,Hydrocinnamic acid,O=C(O)CCc1ccccc1,train
O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1,DB00973,Ezetimibe,DBMET02116,SCH 57871,O=C(CC[C@H]1C(=O)N(c2ccc(F)cc2)[C@@H]1c1ccc(O)cc1)c1ccc(F)cc1,train
COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H]2[C@H]2c3c(cc(CC(=O)O)c(OC)c3O)C[C@@H]([C@@H]1O)N2C)OCO4,DBMET01133,Trabectedin metabolite M8a,DBMET01137,Trabectedin metabolite M16e,COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1C(=O)[C@@H]3Cc5cc(CC(=O)O)c(OC)c(O)c5[C@H]([C@H]21)N3C)OCO4,train
CCCC(=O)O[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,DBMET02913,16alpha-butyrloxyprednisolone,DBMET00353,16-alpha-hydroxyprednisolone,C[C@@]12C=CC(=O)C=C1CCC1C2[C@H](O)C[C@]2(C)C1C[C@H](O)[C@@]2(O)C(=O)CO,train
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5,DB00327,Hydromorphone,DBMET02684,6-β-hydromorphol,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@H](O)CC[C@H]3[C@H]1C5,train
O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1,DB01014,Balsalazide,DBMET00725,4-aminobenzoyl-(beta)-alanine,Nc1ccc(C(=O)NCCC(=O)O)cc1,train
CCO[C@H](COc1ccc(C(F)(F)F)cc1)CSc1ccc(OCC(=O)O)c(C)c1,DB12390,Seladelpar,DBMET03782,O-desethyl-seladelpar,Cc1cc(SC[C@H](O)COc2ccc(C(F)(F)F)cc2)ccc1OCC(=O)O,train
CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,DB00920,Ketotifen,DBMET00961,Nor-ketotifen,O=C1Cc2ccccc2C(=C2CCNCC2)c2ccsc21,train
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21,DB00519,Trandolapril,DBMET00840,Diketopiperazine,O=C1N[C@@H](Cc2cnc[nH]2)C(=O)N2CCCC[C@@H]12,train
C[C@]12CCC(=O)C=C1CC[C@H]1[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F,DB00687,Fludrocortisone,DBMET02845,20β-dihydrofluorocortisol,C[C@]12CCC(=O)C=C1CC[C@H]1[C@@H]3CC[C@](O)(C(O)CO)[C@@]3(C)C[C@H](O)[C@@]12F,train
COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC,DB00565,Cisatracurium,DBMET00636,laudanosine,COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2C)cc1OC,train
CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1,DB09059,Atosiban,DBMET02065,Reduced Metabolite (Atosiban),CCOc1ccc(C[C@@H](NC(=O)CCS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)O)[C@@H](C)CC)cc1,train
Clc1ccccc1CN1CCc2sccc2C1,DB00208,Ticlopidine,DBMET00618,7-Hydroxyticlopidine,OC1CN(Cc2ccccc2Cl)Cc2ccsc21,train
N#C[C@@]1(c2ccc3c(N)ncnn23)O[C@H](COP(=O)([O-])[O-])[C@@H](O)[C@H]1O,DBMET03036,Remdesivir Nucleoside Monophosphate,DBMET03038,Remdesivir Nucleoside Triphosphate,N#C[C@@]1(c2ccc3c(N)ncnn23)O[C@H](CO[P@](=O)([O-])O[PH](=O)(=O)O[PH](=O)(=O)[O-])[C@@H](O)[C@H]1O,train
CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,DB01017,Minocycline,DBMET03013,Minocycline M7 Metabolite,CN[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(N(C)C)c4C[C@H]3C[C@@H]12,train
NC[C@H](O)c1ccc(O)c(O)c1,DB00368,Norepinephrine,DBMET00563,3-Methoxy-4-Hydroxyphenylglycol sulfate,COc1cc(C(CO)OS(=O)(=O)O)ccc1O,train
CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,DB05521,Telaprevir,DBMET00993,Pyrazinoic acid,O=C(O)c1cnccn1,train
CNC[C@H](O)c1ccc(O)c(O)c1,DB00668,Epinephrine,DBMET00537,Epinephrine sulfate,CNC[C@H](O)c1ccc(OS(=O)(=O)O)c(O)c1,train
CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)Oc1ccccc1,DB14761,Remdesivir,DBMET03214,Remdesivir carboxylate,C[C@H](N[P@](=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)Oc1ccccc1)C(=O)[O-],train
CCn1c(C(C)=O)nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c1=O,DBMET02172,Oxo-etoperidone (M3),DBMET02173,Etoperidone M16,CCn1c(C(C)=O)nn(CCC(=O)OC)c1=O,train
CC(C)(Cc1ccccc1)NO,DBMET02228,N-hydroxyphentermine,DBMET02229,Nitrophentermine,CC(C)(Cc1ccccc1)[N+](=O)[O-],train
CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DB01026,Ketoconazole,DBMET02655,M9 (Ketoconazole),CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)C(O)C1,train
Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,DB00709,Lamivudine,DBMET00899,Lamivudine-triphosphate,Nc1ccn(C2CSC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)n1,train
O=C(O)COc1nn(Cc2ccccc2)c2ccccc12,DB13501,Bendazac,DBMET02188,5-hydroxybendazac,O=C(O)COc1nn(Cc2ccccc2)c2ccc(O)cc12,train
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,DB01406,Danazol,DBMET00674,17-hydroxymethylethisterone,C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)[C@H](CO)C[C@]4(C)[C@H]3CC[C@@]21C,train
C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12,DB04630,Aldosterone,DBMET00598,Aldosterone 18-glucuronide,C[C@]12CCC(=O)C=C1CCC1C3CC[C@H](C(=O)CO)C34C[C@@H](OC4O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)C12,train
Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,DB00543,Amoxapine,DBMET00776,8-hydroxyamoxapine,Oc1ccc2c(c1)N=C(N1CCNCC1)c1cc(Cl)ccc1O2,train
N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,DB01235,Levodopa,DBMET02439,Levodopa Methylated Metabolite,COc1cc(C[C@H](N)C(=O)O)ccc1O,train
CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1O,DBMET02554,4-hydroxy-13-cis-retinoic acid,DBMET02552,4-oxo-13-cis-retinoic acid,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1=O,train
CCCC(C(=O)O)C(O)CC,DBMET00062,3-Hydroxyvalproic acid,DBMET01110,3-Oxovalproic acid,CCCC(C(=O)O)C(=O)CC,train
CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,DB06697,Artemether,DBMET00826,Deoxyartemsinin,C[C@@H]1C=C[C@H]2C3[C@@H](OC(=O)[C@@H]2C)O[C@](C)(O)CC[C@H]31,train
Cc1c(OCC(F)(F)F)ccnc1C[S@@+]([O-])c1nc2c(OS(=O)(=O)O)cccc2[nH]1,DBMET03755,4-Sulfonyloxy dexlansoprazole,DBMET03757,4-Sulfonyloxy dexlansoprazole sulfide,Cc1c(OCC(F)(F)F)ccnc1CSc1nc2cccc(OS(=O)(=O)O)c2[nH]1,train
Cc1cn2nc(-c3cc(=O)n4cc(N5CCNC6(CC6)C5)ccc4n3)cc(C)c2n1,DB15305,Risdiplam,DBMET03205,Risdiplam M1 metabolite,Cc1cn2nc(-c3cc(=O)n4cc(N5CCN(O)C6(CC6)C5)ccc4n3)cc(C)c2n1,train
CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O,DB13345,Dihydroergocristine,DBMET02090,8'-hydroxy-dihydroergocristine,CC(C)[C@@]1(N=C(O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCC(O)N3C(=O)[C@H](Cc3ccccc3)N2C1=O,train
O=C(O)CC/C(=N/Nc1nncc2ccccc12)C(=O)O,DBMET02817,α-ketoglutarate hydrazone,DBMET02815,Phthalazinone,O=c1[nH]ncc2ccccc12,train
CCN(CC)C(=O)C1(c2ccccc2)CC1CNC(=O)O,DBMET02300,Milnacipran carbamic acid,DBMET02301,Milnacipran carbamoyl O-glucuronide,CCN(CC)C(=O)C1(c2ccccc2)CC1CNC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,train
CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,DB09089,Trimebutine,DBMET01503,Nortrimebutine,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(NC)c1ccccc1,train
COc1cc(O)c(N)c(C(=O)Nc2ccc(Cl)cn2)c1,DBMET01538,PRT062982,DBMET01539,PRT063069,COc1cc(OS(O)(O)O)c(N)c(C(=O)Nc2ccc(Cl)cn2)c1,train
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,DB00471,Montelukast,DBMET01243,Montelukast metabolite M1,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)OC2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,train
C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O,DB00190,Carbidopa,DBMET00702,3-(4-hydroxy-3-methoxyphenyl)-2-methylpropionic acid,COc1cc(CC(C)C(=O)O)ccc1O,train
CN1CC[C@@H](NC(=O)Nc2ccc(C#N)cc2)C[C@@H]1c1nc2ccccc2[nH]1,DB11978,Glasdegib,DBMET02213,Glasdegib M11,CN1CC[C@@H](NC(=O)Nc2ccc(C#N)c([O-])c2)C[C@@H]1c1nc2ccccc2[nH]1,train
CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1,DB00585,Nizatidine,DBMET00959,N2-monodes-methylnizatidine,CNCc1nc(CSCCN/C(=C/[N+](=O)[O-])NC)cs1,train
CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1,DB01217,Anastrozole,DBMET02829,"3,5-Bis-(2-methylpropiononitrile)-benzoic acid",CC(C)(C#N)c1cc(C(=O)O)cc(C(C)(C)C#N)c1,train
CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,DB00829,Diazepam,DBMET00831,desmethyldiazepam,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1,train
CN1CC[C@]23c4c5ccc(OCCN6CCOCC6)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,DB09209,Pholcodine,DB00295,Morphine,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,train
CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,DB02789,Pregnenolone,DBMET00500,17-Hydroxypregnenolone sulfate,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CC=C4CC(OS(=O)(=O)O)CC[C@]4(C)[C@H]3CC[C@@]21C,train
CCC(C)C(C(CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(Cc1ccccc1)C(=O)O)OC)N(C)C(=O)C(NC(=O)C(NC)C(C)C)C(C)C,DBMET03200,Monomethyl Auristatin-F,DBMET03204,Monomethyl Auristatin-F M6 Metabolite,CCC(C)C(C(CC(=O)N1CCCC1C(O)C(C)C(=O)NC(Cc1ccccc1)C(=O)O)OC)N(C)C(=O)C(NC(=O)C(NC)C(C)C)C(C)C,train
O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F,DB00322,Floxuridine,DBMET00855,alpha-Fluoro-beta-alanine,NCC(F)C(=O)O,train
CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1=O,DBMET02552,4-oxo-13-cis-retinoic acid,DBMET02550,4-oxo-all-trans-retinoic acid,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1=O,train
C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1,DB00865,Benzphetamine,DBMET00634,Methamphetamine,CN[C@@H](C)Cc1ccccc1,train
COc1ccc2c3c1O[C@H]1CC(=O)C=C[C@@]31CCN(C)C2,DBMET03148,Galantaminone,DBMET03150,Epigalantamine,COc1ccc2c3c1O[C@H]1C[C@H](O)C=C[C@@]31CCN(C)C2,train
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,DB09073,Palbociclib,DBMET02373,Palbociclib M5,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNC(=O)C4)cn3)nc2n(C2CCCC2)c1=O,train
CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1O,DBMET03303,4'-desethyl-drotaverine,DBMET03304,4'-desethyl-drotaveraldine,CCOc1cc2c(cc1O)CCNC2C(=O)c1ccc(OCC)c(OCC)c1,train
CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,DB13751,Glycyrrhizic acid,DBMET00488,Glucuronic acid,O=C(O)[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O,train
CC(O)CCc1ccc2cc(OC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)ccc2c1,DBMET02538,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (6-OH conjugated),DBMET02539,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (6-OH conjugated) glycine conjugate,CC(O)CCc1ccc2cc(OC3O[C@H](C(=O)NCC(=O)O)[C@@H](O)[C@H](O)[C@H]3O)ccc2c1,train
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@H]3[C@H]1C5,DBMET02685,6-α-hydromorphol,DBMET02726,6-α-hydromorphol glucuronide conjugate 1,CN1CC[C@]23c4c5ccc(OC6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O)c4O[C@H]2[C@@H](O)CC[C@H]3[C@H]1C5,train
CCN(CC)CC(=O)Nc1c(C)cccc1C,DB00281,Lidocaine,DBMET01089,"2,6-Dimethylaniline (2,6-Xylidine)",Cc1cccc(C)c1N,train
CC(=O)N1CCN(c2ccc(OCC3COC(CN4C=NCC4=O)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DBMET02661,Ketoconazole ketone intermediate,DBMET02662,Ketoconazole ketone hydroxyl intermediate,CC(=O)N1CCN(c2ccc(OCC3COC(CN4C(=O)CNC4O)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,train
O=C1O[C@H]([C@@H](O)CO)C(=O)C1=O,DBMET03074,Dehydroascorbate,DBMET03075,"2,3-dikeogulonic acid",O=C(O)C(=O)C(=O)C(O)C(O)CO,train
NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,DB02638,Terlipressin,DB14642,Lypressin,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,train
CN1CC[C@]23c4c5ccc(O)c4OC2[C@@H](O)C=CC3C1C5,DBMET00313,morphine,DB06409,Morphine glucuronide,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)C=C[C@H]3[C@H]1C5,train
N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,DB01261,Sitagliptin,DBMET02432,Sitagliptin Unnamed Metabolite,O=C(O)N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,train
CN1C(=O)C(O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21,DB13872,Lormetazepam,DBMET01529,Lormetazepam glucuronide,CN1C(=O)C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21,train
C[C@H]1CNCCc2ccc(Cl)cc21,DB04871,Lorcaserin,DBMET00927,N-carbamoyl glucuronide lorcaserin,CC1CN(C(=O)OC2O[C@@H](C(=O)O)[C@H](C)[C@@H](C)[C@@H]2C)CCc2ccc(Cl)cc21,train
CC(C)n1c(=O)cc(N[C@@H](C)c2ccc(O)cc2)[nH]c1=O,DBMET03496,MYK-2210,DBMET03498,MYK-2210 glucuronide,CC(C)n1c(=O)cc(N[C@@H](C)c2ccc(OC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)cc2)[nH]c1=O,train
CCN(CC)CCOC(=O)c1ccc(N)cc1Cl,DB01161,Chloroprocaine,DBMET01430,diethylaminoethanol,CCN(CC)CCO,train
NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1O,DBMET03217,Lonafarnib metabolite M1,DBMET03218,Lonafarnib metabolite M2,NC(=O)N1C=CC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1,train
CC(C)Cc1ccc(C(C)C(=O)O)cc1,DB01050,Ibuprofen,DBMET00668,1-hydroxyibuprofen,CC(C(=O)O)c1ccc(C(O)C(C)C)cc1,train
CCCCNc1ccc(C(=O)OCCN(C)C)cc1,DB09085,Tetracaine,DBMET01429,para-aminobenzoic acid,Nc1ccc(C(=O)O)cc1,train
Clc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1,DB13941,Piperaquine,DBMET01946,M3 (piperaquine),OC1CN(c2ccnc3cc(Cl)ccc23)CCN1CCCN1CCN(c2ccnc3cc(Cl)ccc23)CC1,train
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=NOCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O,DB00778,Roxithromycin,DBMET00828,descladinose roxithromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)CC(N(C)C)C2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O,train
CC/C=C(\CCC)C(=O)O,DBMET00065,2-ene-Valproic acid,DBMET00062,3-Hydroxyvalproic acid,CCCC(C(=O)O)C(O)CC,train
O=C(O)CNC(=O)c1cccc([123I])c1,DBMET01492,m-Iodohippuric acid,DBMET01493,Radioiodide 123,[123I-],train
CC(CCc1ccccc1)n1ccc2cc(O)c(O)c(C(N)=O)c21,DBMET02676,Labetalol Theoretical Metabolite (IX),DBMET02678,Labetalol Glucuronide Metabolite (XI),CC(CCc1ccccc1)n1ccc2cc(O)c(OC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)c(C(N)=O)c21,train
CCOC(=O)[C@H](CCc1ccccc1)N1C(=O)C2Cc3ccccc3CN2C(=O)C1C,DBMET02775,Quinapril Metabolite PD109488,DBMET02776,Quinapril Metabolite PD113413,CC1C(=O)N2Cc3ccccc3CC2C(=O)N1[C@@H](CCc1ccccc1)C(=O)O,train
COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-],DB09229,Aranidipine,DBMET01949,Aranidipine M-1,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)O)C1c1ccccc1[N+](=O)[O-],train
CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl,DB09166,Etizolam,DBMET01525,alpha-hydroxyetizolam,Cc1nnc2n1-c1sc(C(C)O)cc1C(c1ccccc1Cl)=NC2,train
CC(=O)CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,DBMET02882,Acalabrutinib M23 Metabolite (ACP-5134),DBMET02884,Acalabrutinib M24 Metabolite,CCCC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12.O.O,train
C[N+](C)(C)C[C@H](O)CC(=O)[O-],DB00583,Levocarnitine,DBMET00513,Trimethylamine N-oxide,C[N+](C)(C)[O-],train
O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O,DB13178,Inositol,DBMET00488,Glucuronic acid,O=C(O)[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O,train
OC[C@@H](O)[C@H](O)[C@@H](O)CO,DB11195,Xylitol,DB03947,D-Xylulose,O=C(CO)[C@@H](O)[C@@H](O)CO,train
CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,DB01155,Gemifloxacin,DBMET00922,N-acetyl gemifloxacin,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1NC(C)=O,train
C[C@@H](O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,DB12406,Lisofylline,DBMET03231,"M3, Pentoxifylline internal diol",C[C@@H](O)C(O)CCCn1c(=O)c2c(ncn2C)n(C)c1=O,train
Oc1cccc2cccnc12,DB11145,Oxyquinoline,DBMET02060,Sulfate Conjugate (Oxyquinoline),[O-]S([O-])([O-])Oc1cccc2cccnc12,train
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)O,DBMET02403,M10 (GW694301X),DBMET03674,M26 fluticasone furoate,C[C@@H]1C[C@H]2[C@@H]3C[C@H](O)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)O,train
CC(=O)N[C@@H](CC(C)C)C(=O)O,DB16956,L-Acetylleucine,DB00149,Leucine,CC(C)C[C@H](N)C(=O)O,train
N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N(CC(=O)O)CC(=O)O)cc3)n2)cc1,DBMET03717,Momelotinib M5 metabolite,DBMET03718,Momelotinib M16 metabolite,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(NCCO)cc3)n2)cc1,train
CCn1c(=O)c2c(nc(/C=C/c3ccc(O)c(OC)c3)n2C)n(CC)c1=O,DBMET02750,4'-O-monodesmethyl istradefylline (M1),DBMET02751,M1 Sulfate Conjugate (M4),CCn1c(=O)c2c(nc(/C=C/c3ccc(OS(=O)(=O)[O-])c(OC)c3)n2C)n(CC)c1=O,train
Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21,DB06769,Bendamustine,DBMET01423,monohydroxy-bendamustine (bendamustine metabolite HP1),Cn1c(CCCC(=O)O)nc2cc(N(CCO)CCCl)ccc21,train
Cc1cccc(C)c1N,DBMET01089,"2,6-Dimethylaniline (2,6-Xylidine)",DBMET01128,2-Amino-3-methylbenzoate,Cc1cccc(C(=O)O)c1N,train
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,DB00714,Apomorphine,DBMET03132,Apomorphine 11-glucuronide,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(OC2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)c1-3,train
C[C@]12CCC(=O)CC1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,DBMET02830,5-alpha androstanedione,DBMET02831,5-alpha androsterone,C[C@]12CCC(O)CC1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,train
CCN1C(=O)CC[C@@]1(O)CNC(=O)c1c(OC)ccc(Br)c1OC,DBMET03195,Remoxipride Metabolite NCM 001,DBMET03196,Remoxipride Metabolite NCM 009,COc1ccc(Br)c(OC)c1C(=O)NC[C@]1(O)CCC(=O)N1,train
CSc1ccccc1C(=N)N1CCN(CCc2cc3c(cc2Cl)NC(=O)C3)CC1,DBMET02993,S-Methyl-dihydro-ziprasidone,DBMET02994,S-Methyl-dihydro-ziprasidone-sulfoxide,CS(=O)c1ccccc1C(=N)N1CCN(CCc2cc3c(cc2Cl)NC(=O)C3)CC1,train
COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,DB00590,Doxazosin,DBMET02604,"Hydroxylated metabolite, Doxazosin",COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,train
CC(=O)O[C@H]1Cc2ccccc2N(C(N)=O)c2ccccc21,DB09119,Eslicarbazepine acetate,DBMET01408,Eslicarbazepine [(S)-licarbazepine],NC(=O)N1c2ccccc2C[C@@H](O)c2ccccc21,train
CC(=O)Oc1cc(C(F)(F)F)ccc1C(=O)O,DB08814,Triflusal,DBMET00686,2-hydroxy-4-trifluoromethyl benzoic acid,O=C(O)c1ccc(C(F)(F)F)cc1O,train
CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,DB13952,Estradiol acetate,DB00783,Estradiol,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,train
O=C(CCCCCCC(=O)Nc1ccccc1)NO,DB02546,Vorinostat,DBMET00726,4-anilino-4-oxobutanoic acid,O=C(O)CCC(O)=Nc1ccccc1,train
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,DB00806,Pentoxifylline,DBMET03232,"M4, Pentoxifylline C-5 carboxylic acid",Cn1cnc2c1c(=O)n(CCCCC(=O)O)c(=O)n2C,train
O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1,DB12473,Taurolidine,DBMET03765,Hydroxymethyl taurultam,O=S1(=O)CCN(CO)CN1,train
CC(C)CC(O)NC(=O)CNC(=O)c1cc(Cl)ccc1Cl,DBMET03787,Ixazomib M5 metabolite,DBMET03783,Ixazomib M6 metabolite,CC(C)CC(=O)NC(=O)CNC(=O)c1cc(Cl)ccc1Cl,train
COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1,DB06605,Apixaban,DBMET02426,Apixaban M2 metabolite,NC(=O)c1nn(-c2ccc(O)cc2)c2c1CCN(c1ccc(N3CCCCC3=O)cc1)C2=O,train
CC(=O)N1CCN(c2ccc(OCC3COC(CN4C(=O)CNC4O)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DBMET02662,Ketoconazole ketone hydroxyl intermediate,DBMET02664,M5 (Ketoconazole),CC(=O)N1CCN(c2ccc(OCC3COC(CN4C(=O)CNC4=O)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,train
CC(=O)CCc1ccc2cc(O)ccc2c1,DBMET02543,4-(6-Hydroxy-2-naphthyl)- butan-2-one,DBMET02545,4-(6-Hydroxy-2-naphthyl)- butan-2-one glucuronide,CC(=O)CCc1ccc2cc(OC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)ccc2c1,train
Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1,DB00648,Mitotane,DBMET03760,Mitotane β-hydroxylated metabolite,OC(Cl)(Cl)C(c1ccc(Cl)cc1)c1ccccc1Cl,train
COc1ccc(OC)c(C(O)CNC(=O)CN)c1,DB00211,Midodrine,DBMET00829,desglymidodrine,COc1ccc(OC)c(C(O)CN)c1,train
COc1ccc2cc(CCC(C)=O)ccc2c1,DB00461,Nabumetone,DBMET02535,4-(6-Methoxy-2-naphthyl)- butan-2-ol,COc1ccc2cc(CCC(C)O)ccc2c1,train
NC(CCCCCNOC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)C(=O)O,DBMET03073,Biocytin,DB00121,Biotin,O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,train
CCc1nn(CCC(=O)O)c(=O)n1CC,DBMET02182,Etoperidone M12,DBMET02184,Etoperidone M13,CCc1nn(CCC(=O)OC)c(=O)n1CC,train
CC(CN1c2ccccc2Sc2ccccc21)N(C)C,DB01069,Promethazine,DBMET02973,Desmethylpromethazine,CNC(C)CN1c2ccccc2Sc2ccccc21,train
CNC1(c2ccccc2Cl)CCCCC1=O,DB01221,Ketamine,DBMET00192,4-Hydroxyketamine,CNC1(c2ccccc2Cl)CC(O)CCC1=O,train
CNC1(c2ccccc2Cl)CCCC(O)C1=O,DBMET00190,6-Hydroxyketamine,DBMET01310,6-Hydroxynorketamine,NC1(c2ccccc2Cl)CCCC(O)C1=O,train
COc1ccc2[nH]c([S@@](=O)Cc3ncc(C)c(OC)c3C)nc2c1,DB00736,Esomeprazole,DBMET01164,Active Metabolite of Esomeprazole,COc1ccc2nc3n(c2c1)SCc1c(C)c(OC)c(C)c[n+]1-3,train
O=C(O[C@@H]1[C@@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@H](O)[C@H](OC(=O)c2cccnc2)[C@H]1OC(=O)c1cccnc1)c1cccnc1,DBMET01486,Inositol pentanicotinate,DBMET01487,Inositol tetranicotinate,O=C(O[C@H]1[C@H](OC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@@H](O)[C@@H](O)[C@@H]1OC(=O)c1cccnc1)c1cccnc1,train
CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21,DB00779,Nalidixic acid,DBMET00887,Hydroxynalidixic acid,CCn1cc(C(=O)O)c(=O)c2ccc(CO)nc21,train
O=C(O)C(=O)O[Pt]1(Cl)N[C@@H]2CCCC[C@H]2N1,DBMET03682,Monochloro DACH platinum,DBMET03683,Dichloro DACH platinum,Cl[Pt]1(Cl)N[C@@H]2CCCC[C@H]2N1,train
CN1CC[C@@]23C=C[C@@H](O)C[C@@H]2Oc2c(O)ccc(c23)C1,DBMET03156,O-desmethyl-epigalantamine,DBMET03157,O-desmethyl-epigalantamine glucuronide,CN1CC[C@@]23C=C[C@@H](O)C[C@@H]2Oc2c(OC4C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H]4C(=O)O)ccc(c23)C1,train
COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O,DBMET01521,QS10,DBMET01522,QS8,COC1=C(OC)C(=O)C(CCCCCCCCO)=C(C)C1=O,train
C[C@H](N)Cc1ccc(O)cc1,DBMET03721,4-Hydroxy-d-amphetamine,DBMET03722,4-Hydroxy-norephedrine,C[C@H](N)[C@H](O)c1ccc(O)cc1,train
N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1,DBMET03167,Chloramphenicol Base,DBMET03168,Chloramphenicol Base N-acetyl,CC(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1,train
OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O,DB09082,Vilanterol,DBMET01394,M29 (GW630200),OCCOCCCCCCNC[C@H](O)c1ccc(O)c(CO)c1,train
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1,DB13943,Testosterone cypionate,DB00624,Testosterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,train
NCCCCCC(=O)O,DB00513,Aminocaproic acid,DBMET00501,Adipic acid,O=C(O)CCCCC(=O)O,train
NC(=O)C(CCC(=O)O)N1C(=O)c2ccccc2C1=O,DBMET01115,4-phthalimidoglutaramic acid,DBMET01119,4-(o-carboxybenzamido)glutaramic acid,NC(=O)C(CCC(=O)O)NC(=O)c1ccccc1C(=O)O,train
Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(N)=O)cc21,DBMET03100,M14 (AZ12791138),DBMET03099,M15 (AZ13326637),Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)O)cc21,train
CCCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DB09173,Butyrfentanyl,DBMET02691,4'-hydroxy-butyrfentanyl,CCCC(=O)N(c1ccccc1)C1CCN(CCc2ccc(O)cc2)CC1,train
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2,DB01348,Spirapril,DBMET01142,Spiraprilat,C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2,train
C[C@]12C=CC(=O)CC1[C@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)[C@@H](O)CO,DBMET02855,"6β,11β,17α,20β,21-pentahydroxy-5ξ-pregn-1-en-3-one (M-XV)",DBMET02856,"6β,11β,17α,21-tetrahydroxy-5ξ-pregn-1-en-3,20-dione (M-XIV)",C[C@]12C=CC(=O)CC1[C@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,train
CC#CCn1c(NCCCC(O)C(=O)O)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,DBMET02391,Linagliptin M506(1),DBMET02392,Linagliptin M504(2),CC#CCn1c(NCCCC(=O)C(=O)O)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,train
COC1=C(OC)C(=O)C(CCCCCCCCO)=C(C)C1=O,DBMET01522,QS8,DBMET01523,QS6,COC1=C(OC)C(=O)C(CCCCCCO)=C(C)C1=O,train
CCCCCCC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OC(=O)CCCCCC)CC[C@@H]12,DB13955,Estradiol dienanthate,DB00783,Estradiol,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,train
NS(=O)(=O)Cc1noc2ccccc12,DB00909,Zonisamide,DBMET00923,N-acetyl zonisamide,CC(=O)NS(=O)(=O)Cc1noc2ccccc12,train
COc1ccc2c3c1O[C@H]1[C@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341,DBMET02687,6-β-hydrocodol,DBMET02728,6-β-hydrocodol glucuronide conjugate,COc1ccc2c3c1O[C@H]1[C@H](OC4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341,train
CCC(CO)(NC)c1ccccc1,DBMET01506,2-methylamino-2-phenylbutan-1-ol ,DBMET01507,2-amino-2-phenylbutan-1-ol,CCC(N)(CO)c1ccccc1,train
CC(=O)CCc1ccc2cc(OC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)ccc2c1,DBMET02545,4-(6-Hydroxy-2-naphthyl)- butan-2-one glucuronide,DBMET02546,4-(6-Hydroxy-2-naphthyl)- butan-2-one glucuronide glycine conjugate,CC(=O)CCc1ccc2cc(OC3O[C@H](C(=O)NCC(=O)O)[C@@H](O)[C@H](O)[C@H]3O)ccc2c1,train
COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C,DB00907,Cocaine,DB01515,Benzoylecgonine,CN1[C@H]2CC[C@@H]1[C@@H](C(=O)O)[C@@H](OC(=O)c1ccccc1)C2,train
COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],DB01115,Nifedipine,DBMET02975,"2,6-dimethyl-4-(2-nitrophenyl)-5-methoxycarbonyl-pyridine-3-carboxylic acid",COC(=O)C1=C(C)NC(C)=C(C(=O)O)C1c1ccccc1[N+](=O)[O-],train
C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,DB00390,Digoxin,DBMET02501,Dihydrodigoxin,CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7COC(=O)C7)CCC65O)C4)OC3C)OC2C)CC(O)C1O,train
COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1,DB00643,Mebendazole,DBMET00675,2-amino-5-benzoylbenzimidazole,N=c1[nH]c2ccc(C(=O)c3ccccc3)cc2[nH]1,train
IC(I)I,DB13813,Iodoform,DB05382,Iodine,II,train
CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,DB14185,Aripiprazole lauroxil,DB03017,Lauric acid,CCCCCCCCCCCC(=O)O,train
CN1C(S)=NC(O)C1O,DBMET02760,Methimazole Dihydrodiol Metabolite,DBMET02761,Methimazole Glyoxal Metabolite,CC(=O)C(C)=O,train
CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,DB04855,Dronedarone,DBMET02836,C-dealkyl-dronedarone,CCCCN(CCCC)CCCOc1ccc(C(=O)O)cc1,train
Oc1ncnc2[nH]ncc12,DB00437,Allopurinol,DBMET00414,oxypurinol,O=c1[nH]c(=O)c2cn[nH]c2[nH]1,train
COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,DB01394,Colchicine,DB15534,Colchiceine,COc1cc2c(c(OC)c1OC)-c1ccc(O)c(=O)cc1C(NC(C)=O)CC2,train
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,DB02659,Cholic Acid,DBMET00553,Cholic acid glucuronide,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,train
CCOC(=O)c1ccc(NC(C)=O)cc1,DBMET03291,Acetylbenzocaine,DBMET03290,4-Acetaminobenzoic acid,CC(=O)Nc1ccc(C(=O)O)cc1,train
Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,DB00580,Valdecoxib,DBMET01338,Valdecoxib metabolite M2,Cc1onc(-c2ccccc2)c1-c1ccc(S(=O)(=O)NO)cc1,train
CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O,DB00385,Valrubicin,DBMET00952,N-trifluoroacetyladriamycin,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1,train
Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](C=S(=O)([O-])[O-])OC4=O)cc3F)cn2)n1,DBMET03123,Tedizolid sulphate,DBMET03124,Desmethyl tedizolid sulphate,O=C1O[C@@H](C=S(=O)([O-])[O-])CN1c1ccc(-c2ccc(-c3nn[nH]n3)nc2)c(F)c1,train
CC(CCc1ccc2cc(O)ccc2c1)OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,DBMET02541,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (2-OH conjugated),DBMET02542,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (2-OH conjugated) glycine conjugate,CC(CCc1ccc2cc(O)ccc2c1)OC1O[C@H](C(=O)NCC(=O)O)[C@@H](O)[C@H](O)[C@H]1O,train
COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C,DB01129,Rabeprazole,DBMET01169,Active Metabolite of Rabeprazole,COCCCOc1cc2[n+](cc1C)-c1nc3ccccc3n1SC2,train
O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,DB00795,Sulfasalazine,DB00891,Sulfapyridine,Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1,train
CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1,DB09020,Bisacodyl,DBMET03353,Bis-(p-hydroxyphenyl)-pyridyl-2-methane,Oc1ccc(C(c2ccc(O)cc2)c2ccccn2)cc1,train
COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341,DBMET02686,6-α-hydrocodol,DBMET02685,6-α-hydromorphol,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@H]3[C@H]1C5,train
CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,DB05271,Rotigotine,DBMET00941,N-despropyl-rotigotine,Oc1cccc2c1CCC(NCCc1cccs1)C2,train
COc1ccc(-c2cc(=S)ss2)cc1,DB13853,Anethole trithione,DBMET02057,4-Hydroxy-anethorithion (ATX),Oc1ccc(-c2cc(=S)ss2)cc1,train
CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,DB06590,Ceftaroline fosamil,DBMET00812,ceftaroline,CCO/N=C(\C(O)=N[C@@H]1C(=O)N2C(C(=O)O)=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nc(=NP(=O)(O)O)s[nH]1,train
CCOC(=O)c1c(CS(=O)(=O)c2ccccc2)n(C)c2cc(Br)c(OS(=O)(=O)[O-])c(CN(C)C)c12,DBMET03048,Arbidol M3-1 metabolite,DBMET03050,Arbidol M9-1 metabolite,CCOC(=O)c1c(CSc2ccccc2)[nH]c2cc(Br)c(OS(=O)(=O)[O-])c(CN(C)C)c12,train
CC(O)[C@@]1(O)CCc2c(O)c3c(c(O)c2C1)C(=O)c1cccc(O)c1C3=O,DBMET03407,Demethyl deoxydaunorubicinol aglycone,DBMET03410,Demethyl deoxydaunorubicinol aglycone-4-O-β-glucuronide,CC(O)[C@@]1(O)CCc2c(O)c3c(c(O)c2C1)C(=O)c1cccc(OOC2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)c1C3=O,train
C/C(=C/C(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12)SC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O,DBMET02885,Acalabrutinib M5 Metabolite (ACP-5530),DBMET02886,Acalabrutinib M7 Metabolite (ACP-5531),C/C(=C/C(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12)SC[C@@H](N)C(=O)NCC(=O)O,train
COC(=O)[C@H](c1ccc(O)cc1)[C@H]1CCCCN1,DBMET02407,p-hydroxy-methylphenidate,DBMET03283,p-hydroxy-ritalinic acid,O=C(O)[C@H](c1ccc(O)cc1)[C@H]1CCCCN1,train
CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O,DB00132,alpha-Linolenic acid,DBMET03466,Eicosapentaenoic acid,CC/C=C/C/C=C/C/C=C/C/C=C/C/C=C/CCCC(=O)O,train
COC(=O)c1c(C)nc(C)c(C(=O)OCC(C)=O)c1-c1ccccc1[N+](=O)[O-],DBMET01952,Aranidipine M-3,DBMET01951,Aranidipine M-4,COC(=O)c1c(C)nc(C)c(C(=O)OCC(C)O)c1-c1ccccc1[N+](=O)[O-],train
NC(=O)c1cn(Cc2c(F)cccc2F)nn1,DB06201,Rufinamide,DBMET00814,CGP-47292,O=C(O)c1cn(Cc2c(F)cccc2F)nn1,train
O=C(OOC(=O)c1ccccc1)c1ccccc1,DB09096,Benzoyl peroxide,DBMET01436,Benzoyloxyl radical,O=C([O-])c1ccccc1,train
C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,DB06230,Nalmefene,DBMET01859,Nalmefene 3-O-sulfate,C=C1CC[C@@]2(O)[C@H]3Cc4ccc(OS(=O)(=O)O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,train
Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,DB00495,Zidovudine,DBMET00720,3'-Aminothymidine,Cc1cn([C@H]2C[C@H](N)[C@@H](CO)O2)c(=O)[nH]c1=O,train
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,DB08911,Trametinib,DBMET03641,Trametinib M1 metabolite,Cc1c(=O)n(C)c(Nc2ccc(I)cc2F)c2c(=O)n(C3CC3)c(=O)n(-c3cccc(N)c3)c12,train
O=[As]O[As]=O,DB01169,Arsenic trioxide,DB04456,Arsenous acid,O[As](O)O,train
C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,DB01536,Androstenedione,DBMET02830,5-alpha androstanedione,C[C@]12CCC(=O)CC1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,train
CC(=O)O[C@H](c1ccc([N+](=O)[O-])cc1)[C@@H](CO)NC(=O)C(Cl)Cl,DBMET03159,Chloramphenicol 1-acetate,DBMET03160,"Chloramphenicol 1,3-diacetate",CC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](OC(C)=O)c1ccc([N+](=O)[O-])cc1,train
COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314,DB00497,Oxycodone,DBMET00428,alpha-oxycodol,COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)C(C2)N(C)CC[C@]314,train
CN(C)CCc1c[nH]c2cc(O)c(Cn3cncn3)cc12,DBMET03669,6-Hydroxy rizatriptan,DBMET03670,6-Hydroxy rizatriptan sulfate,CN(C)CCc1c[nH]c2cc(OS(=O)(=O)O)c(Cn3cncn3)cc12,train
CCCC(=O)N(c1ccccc1)C1CCN(CCc2ccc(O)cc2)CC1,DBMET02691,4'-hydroxy-butyrfentanyl,DBMET02692,4'-hydroxy-3'-methoxy-butyrfentanyl,CCCC(=O)N(c1ccccc1)C1CCN(CCc2ccc(O)c(OC)c2)CC1,train
C=CCC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](/C=C(/C)C=O)C2(C)C)CC1=O,DBMET02077,M2 (Bioallethrin),DBMET02078,M3 (Bioallethrin),C=CCC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](/C=C(/C)C(=O)O)C2(C)C)CC1=O,train
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1,DB01112,Cefuroxime,DBMET00328,acetaldehyde,CC=O,train
CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,DB13946,Testosterone undecanoate,DB00624,Testosterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,train
O=C[C@H](O)[C@@H](O)[C@H](O)CO,DB09419,Xylose,DB11195,Xylitol,OC[C@@H](O)[C@H](O)[C@@H](O)CO,train
CC(O)/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,DBMET02703,α-hydroxytamoxifen,DBMET02705,α-hydroxytamoxifen Glucuronide,CC(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,train
CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,DB08881,Vemurafenib,DBMET01854,vemurafenib intermediary metabolite,Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cccc(Cl)c4)cc23)c1F,train
CCC(=O)O,DB03766,Propanoic acid,DB02912,Propanoyl-CoA,CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O,train
O=C(O)c1cc(/N=N/c2ccc(O)c(C(=O)O)c2)ccc1O,DB01250,Olsalazine,DBMET00971,Olsalazine-O-sulfate,O=C(O)c1cc(N=Nc2ccc(OS(=O)(=O)O)c(C(=O)O)c2)ccc1O,train
C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12,DB01409,,DBMET02593,N-methylscopine,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12,train
O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F,DB00432,Trifluridine,DBMET00748,5-carboxy-2'-deoxyuridine,O=C(O)c1cn([C@@H]2C[C@H](O)[C@@H](CO)O2)c(=O)nc1O,train
CCCN1CCCC[C@H]1C(=O)Nc1c(C)cc(O)cc1C,DBMET03532,4-Hydroxyropivacaine,DBMET03534,4-OH-PPX,Cc1cc(O)cc(C)c1NC(=O)[C@@H]1CCCCN1,train
CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)C[N@](Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32,DB11641,Vinflunine,DBMET02055,4-O-deacetylvinflunine,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)C[N@](Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1O)[C@@H]32,train
CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,DB01029,Irbesartan,DBMET01053,Irbesartan derivative M3,O=C(O)CCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,train
COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3ncc(F)cc23)nc1N,DB15456,Vericiguat,DBMET03245,Vericiguat debenzylated metabolite,COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3ncc(F)cc23)nc1N,train
CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(CO)=CC21,DBMET02063,11-hydroxy-THC,DBMET02064,11-Nor-9-carboxy-THC (THC-COOH),CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C(=O)O)=CC21.CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(CO)=CC21,train
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,DB01132,Pioglitazone,DBMET01300,Pioglitazone metabolite M-I,O=C1NC(=O)C(Cc2ccc(O)cc2)S1,train
Nc1ccncc1,DB06637,Dalfampridine,DBMET00709,3-hydroxy-4-aminopyridine sulfate,Nc1ccncc1OS(=O)(=O)O,train
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,DB01001,Albuterol,DBMET01000,Salbutamol 4-O-sulfate,CC(C)(C)NCC(O)c1ccc(OS(=O)(=O)O)c(CO)c1,train
COC(=O)OCOc1c2n(ccc1=O)N([C@@H]1c3ccccc3SCc3c1ccc(F)c3F)[C@@H]1COCCN1C2=O,DB13997,Baloxavir marboxil,DB15675,Baloxavir,O=C1c2c(O)c(=O)ccn2N([C@@H]2c3ccccc3SCc3c2ccc(F)c3F)[C@@H]2COCCN12,train
C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1,DB00728,Rocuronium,DBMET00673,17-desacetyl-rocuronium,C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2O)CCCC1.[Br-],train
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,DB15566,Prednisolone acetate,DB00860,Prednisolone,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,train
CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,DB00985,Dimenhydrinate,DB01075,Diphenhydramine,CN(C)CCOC(c1ccccc1)c1ccccc1,train
C[N+](C)([11CH3])CCO.[Cl-],DB09277,Choline C 11,DBMET01973,betaine,C[N+](C)(C)C(=O)[O-],train
Cc1ccc(Cl)c(OCC(O)CNC(C)(C)C)c1,DB08808,Bupranolol,DBMET00809,"carboxybupranolol, 4-chloro-3-[3-(1,1-dimethylethylamino)-2-hydroxy-propyloxy]benzoic acid",CCCCNCC(O)COc1cc(C(=O)O)ccc1Cl,train
CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1,DB00731,Nateglinide,DBMET01324,Nateglinide metabolite M7,C=C(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1,train
CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OCC=Cc2cnc3ccccc3c2)C[C@@H](C)C(=O)[C@H](C)[C@H]2NC(=O)O[C@@]21C,DB06419,Cethromycin,DBMET03136,10-hydroxy cethromycin,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OCC=Cc2cnc3ccccc3c2)C[C@@H](C)C(=O)[C@H](CO)[C@H]2NC(=O)O[C@@]21C,train
CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CC(=O)O)C[C@H]2C[C@H]1O,DBMET03767,Dinor-iloprost,DBMET03768,Tetranor-iloprost,CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2CC(C(=O)O)C[C@H]2C[C@H]1O,train
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)C2=O,DBMET03004,16-alpha hydroxyestrone,DBMET03005,17-Epiestriol,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@H]2O,train
CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OCC=Cc2cnc3ccccc3c2)C[C@@H](C)C(=O)[C@H](CO)[C@H]2NC(=O)O[C@@]21C,DBMET03136,10-hydroxy cethromycin,DBMET03137,10-hydroxy-N-desmethyl cethromycin,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](NC)[C@H]2O)[C@](C)(OCC=Cc2cnc3ccccc3c2)C[C@@H](C)C(=O)[C@H](CO)[C@H]2NC(=O)O[C@@]21C,train
NC(=O)N1c2ccccc2C[C@@H](O)c2ccccc21,DBMET01408,Eslicarbazepine [(S)-licarbazepine],DBMET01413,Eslicarbazepine-O-glucuronide,NC(=O)N1c2ccccc2C[C@@H](N[C@H](C=O)CCC(=O)O)c2ccccc21,train
O=C(CC[C@H]1C(=O)N(c2ccc(F)cc2)[C@@H]1c1ccc(O)cc1)c1ccc(F)cc1,DBMET02116,SCH 57871,DBMET02117,SCH 57871-glucuronide,O=C(CC[C@H]1C(=O)N(c2ccc(F)cc2)[C@@H]1c1ccc(OC2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)cc1)c1ccc(F)cc1,train
C/C1=C2/N=C(/C=C3\N=C(/C(C)=C4/[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@](C)([C@@H]5N=C1[C@](C)(CCC(=O)NC[C@@H](C)OP(=O)([O-])O[C@H]1[C@@H](O)[C@@H](n6cnc7cc(C)c(C)cc76)O[C@@H]1CO)[C@H]5CC(N)=O)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]2CCC(N)=O,DB00115,Cyanocobalamin,DB03614,Mecobalamin,CC1=C2N3[C@@H]4[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(=O)([O-])O[C@H]2[C@@H](O)[C@H](O[C@@H]2CO)n2c[n+](c5cc(C)c(C)cc52)[Co-3]325(C)[N+]3=C1[C@@H](CCC(N)=O)C(C)(C)C3=CC1=[N+]2C(=C(C)C2=[N+]5[C@]4(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O)[C@@](C)(CC(N)=O)[C@@H]1CCC(N)=O,train
C=C1C=CC=C/C1=N\c1c(Cl)cccc1Cl,DBMET02617,diclofenac o-imine methine,DBMET02618,"2-(2,6-dichlorophenylamino)-benzyl-S-thioether glutathione",N[C@@H](CCC(=O)N[C@@H](CSCC1C=CC=C/C1=N\c1c(Cl)cccc1Cl)C(=O)NCC(=O)O)C(=O)O,train
CS(C)=O,DB01093,Dimethyl sulfoxide,DBMET00551,Dimethyl sulfide,CSC,train
O=C(O[C@H]1[C@H](OC(=O)c2cccnc2)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1OC(=O)c1cccnc1)c1cccnc1,DBMET01488,Inositol trinicotinate,DBMET01489,Inositol dinicotinate,O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1OC(=O)c1cccnc1)c1cccnc1,train
Cc1ccccc1C(OCCN(C)C)c1ccccc1,DB01173,Orphenadrine,DBMET00929,N-demethyl orphenadrine,CNCCOC(c1ccccc1)c1ccccc1C,train
C[C@H](N[P@@](=O)([O-])OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)C(=O)[O-],DBMET03035,Remdesivir Alanine Metabolite (Ala-Met; GS-704277),DBMET03036,Remdesivir Nucleoside Monophosphate,N#C[C@@]1(c2ccc3c(N)ncnn23)O[C@H](COP(=O)([O-])[O-])[C@@H](O)[C@H]1O,train
O=C1O[Bi](O)Oc2ccccc21,DB01294,Bismuth subsalicylate,DB14572,Bismuth cation,[Bi+3],train
CC(=O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,DB00414,Acetohexamide,DBMET00884,Hydroxyhexamide,CC(O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,train
CC1(CO)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,DBMET02999,Amoxicillin M3 Metabolite,DBMET03000,Amoxicillin M4 Metabolite,CC1(C=O)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,train
COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,DB09079,Nintedanib,DBMET01384,BIBF 1202,CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(O)=Nc4cc(C(=O)O)ccc43)c3ccccc3)cc2)CC1,train
C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)[C@@H](O)CO,DBMET02861,20β-dihydro-prednisone (M-IV),DBMET02862,"17α,20ξ,21-trihydroxy-5ξ-pregn-1-en-3,11-dione(M-XVIII)",C[C@]12C=CC(=O)C[C@@H]1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(O)CO,train
Cn1c(CN)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DBMET03385,Dabigatran M354,DBMET03386,Dabigatran M396,CC(=O)NCc1nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc2n1C,train
CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1,DB08816,Ticagrelor,DBMET03171,AR-C133913XX,CCCSc1nc(N)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1,train
COc1ccc2cc([C@H](C)C(=O)O)ccc2c1,DB00788,Naproxen,DBMET00160,Naproxen O-glucuronide,COc1ccc2cc([C@H](C)C(=O)OC3O[C@H](C(=O)O)[C@@H](C)[C@H](C)[C@H]3C)ccc2c1,train
Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCC(O)NC1=O,DBMET03070,Lopinavir M3/M4 metabolite(s),DBMET03071,Lopinavir M1 metabolite,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCC(=O)NC1=O,train
CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C,DB00378,Dydrogesterone,DBMET00695,20-dihydrodydrogesterone,C=C1C=C2C=CC3C(CCC4(C)C(C(C)C)CCC34)C2(C)CC1,train
Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](COP(=O)(O)O)OC4=O)cc3F)cn2)n1,DB09042,Tedizolid phosphate,DB14569,Tedizolid,Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](CO)OC4=O)cc3F)cn2)n1,train
CCN1C(=O)NC(c2ccccc2)C1=O,DB00754,Ethotoin,DBMET00979,p-Hydroxyl-ethotoin,CCN1C(=O)NC(c2ccc(O)cc2)C1=O,train
CC(C(=O)O)c1cccc(Oc2ccccc2)c1,DB00573,Fenoprofen,DBMET00744,4'-hydroxyfenoprofen glucuronide,CC(C(=O)O)c1cccc(Oc2ccc(O[C@H]3[C@H](O)[C@@H](C(=O)O)OC(O)[C@@H]3O)cc2)c1,train
O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F,DB01195,Flecainide,DBMET00905,Meta-O-dealkylated flecainide,O=C(NCC1CCCCN1)c1cc(O)ccc1OCC(F)(F)F,train
CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12,DB09084,Benzydamine,DBMET02061,Benzydamine N-oxide,C[N+](C)([O-])CCCOc1nn(Cc2ccccc2)c2ccccc12,train
CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,DB00836,Loperamide,DBMET03540,Loperamide carbinolamide metabolite,CN(CO)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,train
CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1,DB00799,Tazarotene,DBMET01005,Tazarotenic acid,CC1(C)CCSc2ccc(C#Cc3ccc(C(=O)O)cn3)cc21,train
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,DB01224,Quetiapine,DBMET02795,Quetiapine sulfoxide,O=S1c2ccccc2N=C(N2CCN(CCOCCO)CC2)c2ccccc21,train
CN1CCCC1,DBMET03516,N-Methylpyrrolidine,DBMET00960,N-methylpyrrolidine N-oxide,C[N+]1([O-])CCCC1,train
CC(C)C[C@H](CN)CC(=O)O,DB00230,Pregabalin,DBMET01540,N-methylpregabalin,CC(C)C(C)[C@H](CN)CC(=O)O,train
NNCCc1ccc(O)cc1,DBMET01955,4- hydroxyphenelzine,DBMET01954,4-hydroxyphenylacetic acid,O=C(O)Cc1ccc(O)cc1,train
C[C@]12C=CC(=O)C=C1[C@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)[C@H](O)CO,DBMET02857,"6β,11β,17α,20α,21-pentahydroxypregnan-1,4-diene-3-one (M-IX)",DBMET02858,"6β,11β,17α,20α,21-pentahydroxy-5ξ-pregn-1-en-3-one (M-XVI)",C[C@]12C=CC(=O)CC1[C@H](O)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)[C@H](O)CO,train
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,DB00169,Cholecalciferol,DBMET00609,"(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide)",C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)C[C@H](OC3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)C(=O)C(C)(C)O)CC[C@@H]12,train
CC#CCn1c(NCCCC(=O)C(=O)O)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,DBMET02392,Linagliptin M504(2),DBMET02393,Linagliptin M476(1),CC#CCn1c(NCCCC(=O)O)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,train
COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,DB00843,Donepezil,DBMET02730,6-O-desmethyl donepezil,COc1cc2c(cc1O)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,train
NCCC[C@H](N)C(=O)O,DB00129,Ornithine,DBMET00502,L-Arginine,N=C(N)NCCC[C@H](N)C(=O)O,train
CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(O)cc13,DB14682,Dextrorphan,DBMET01317,Dextrorphan sulfate,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(OS(=O)(=O)O)cc13,train
CCC(CC)C(=O)OCOC(=O)C1=C(S[C@H]2CC[S@@+]([O-])C2)S[C@@H]2[C@@H]([C@@H](C)O)C(=O)N12,DB16335,Sulopenem etzadroxil,DB15284,Sulopenem,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@H]3CC[S@@+]([O-])C3)S[C@H]12,train
CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC,DB00790,Perindopril,DBMET00986,Perindoprilat glucuronide,CCC(NC(C)C(=O)N1[C@H](C(=O)O[C@]2(C(=O)O)O[C@H](C)[C@@H](O)[C@H](O)[C@H]2O)C[C@@H]2CCCC[C@@H]21)C(=O)O,train
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)C=C[C@H]3[C@H]1C5,DB06409,Morphine glucuronide,DBMET02018,"morphine-3,6-diglucuronide",OC1OC(Oc2ccc3c4c2OC2C(OC5OC(O)C(O)C(O)C5O)C=CC5C(C3)NCC[C@@]452)C(O)C(O)C1O,train
CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,DB00335,Atenolol,DBMET02487,Atenolol-glucuronide conjugate,CC(C)NCC(COc1ccc(CC(N)=O)cc1)OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,train
Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,DB12015,Alpelisib,DBMET02571,Alpelisib M4 Metabolite,Cc1nc(NC(=O)N2CCC[C@H]2C(=O)O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,train
C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,DB00136,Calcitriol,DBMET00575,Calcitroic acid,C=C1/C(=C/C=C2\CCC[C@]3(C)[C@@H]([C@H](C)CC(=O)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,train
Nc1ccc(/N=N/c2ccccc2)c(N)n1,DB01438,Phenazopyridine,DBMET02708,"2,3,6 Triaminopyridine",N=c1ccc(N)c(N)[nH]1,train
CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1C,DBMET03309,Ponesimod M32 Metabolite,DBMET03310,Ponesimod M48 Metabolite,CCC/N=C1\S/C(=C\c2ccc(O)c(Cl)c2)C(O)N1c1ccccc1C,train
O=C1CCO1,DB09348,Propiolactone,DBMET02013,hydracrylic acid derivatives,O=CCCO,train
O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21,DB00121,Biotin,DBMET03072,Biotin Holocarboxylase Metabolite,NCC(=O)NC(CCCCCNOC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)C(=O)NCC(=O)O,train
C=C(C)[C@H]1CC=C(C)CC1,DB08921,(4R)-limonene,DBMET01190,Uroterpenol,CC1=CCC(C(C)(O)CO)CC1,train
CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,DB00599,Thiopental,DB00312,Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,train
CN(C)CCC(c1ccccc1)c1ccccn1,DB01620,Pheniramine,DBMET02635,N-desmethylpheniramine,CNCCC(c1ccccc1)c1ccccn1,train
C[C@]12CCC(=O)C(O)=C1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,DB08905,Formestane,DBMET00579,4-Hydroxyandrostenedione glucuronide,C[C@]12CCC(=O)C(O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)=C1CCC1C2CC[C@]2(C)C(=O)CCC12,train
N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(NCCO)cc3)n2)cc1,DBMET03718,Momelotinib M16 metabolite,DBMET03719,Momelotinib M17 metabolite,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N)cc3)n2)cc1,train
Nc1ccc(O)c(C(=O)O)c1,DB00244,Mesalazine,DBMET03621,N-acetyl-5-aminosalicylic acid,CC(=O)Nc1ccc(O)c(C(=O)O)c1,train
CC1O[C@@]2(CS1)CN1CCC2CC1,DB00185,Cevimeline,DBMET00488,Glucuronic acid,O=C(O)[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O,train
CCC(=O)C1=C(C)NC(C)=C(C(=O)O)C1c1ccccc1[N+](=O)[O-],DBMET01950,Aranidipine M-2,DBMET01953,Aranidipine M-5,COC(=O)c1c(C)nc(C)c(C(=O)O)c1-c1ccccc1[N+](=O)[O-],train
CCCCCOc1ccc(-c2ccc(-c3ccc(/C(O)=N/[C@H]4C[C@@H](O)[C@@H](OCC[N+](C)(C)C)/N=C(/O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@@H](C)O)/N=C(/O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)cc5)/N=C(/O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)/N=C\4O)cc3)cc2)cc1,DB16310,Rezafungin,DBMET03648,Despentyl-rezafungin,C[C@@H](O)[C@@H]1/N=C(/O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)/N=C(/O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)/N=C(/O)[C@@H](/N=C(\O)c2ccc(-c3ccc(-c4ccc(O)cc4)cc3)cc2)C[C@@H](O)[C@@H](OCC[N+](C)(C)C)/N=C(/O)[C@@H]2[C@@H](O)[C@@H](C)CN2C1=O,train
CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O,DB09292,Sacubitril,DBMET01401,Sacubitrilat (LBQ657),C[C@H](C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O)C(=O)O,train
CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)C(O)C1,DBMET02655,M9 (Ketoconazole),DBMET02657,Ketoconazole iminium ion,CC(=O)N1CC=[N+](c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,train
COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,DB12147,Erdafitinib,DBMET03650,M8 Erdafitinib,COc1cc(Nc2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(OC)c1,train
C=CCC1=C(C)C(OC(=O)C2C(C=C(C)C)C2(C)C)CC1=O,DB13746,Bioallethrin,DBMET02076,M1 (Bioallethrin),C=CCC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](/C=C(/C)CO)C2(C)C)CC1=O,train
CC(=O)N1CCN(c2ccc(OCC3COC(CNC=N)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,DBMET02667,M3 (Ketoconazole),DBMET02668,M4 (Ketoconazole),CC(=O)N1CCN(c2ccc(OCC3COC(CN)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,train
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,DB00864,Tacrolimus,DBMET00670,13-demethyl tacrolimus,C=CC[C@@H]1/C=C(/C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2O,train
C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2ncc(O)c3ccc(Cl)cc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,DBMET02050,BMS-798430,DBMET02051,BMS-558364,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,train
CN(C)CCC=C1c2ccccc2COc2ccccc21,DB01142,Doxepin,DBMET00844,Doxepin N-oxide,C[N+](C)([O-])CC/C=C1\c2ccccc2COc2ccccc21,train
CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,DB00507,Nitazoxanide,DBMET01013,Tizoxanide glucuronide,O=C(Nc1ncc([N+](=O)[O-])s1)c1ccccc1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O,train
COc1ccc(CN2CCNCC2)c(OC)c1O,DBMET03344,3-desmethyltrimetazidine,DBMET03349,3-desmethyltrimetazidine O-sulphate,COc1ccc(CN2CCNCC2)c(OC)c1OS(=O)(=O)[O-],train
CC(CC=O)CCCC(C)(C)O,DB14187,Hydroxycitronellal,DBMET02123,7-hydroxycitronellylic acid,CC(CCCC(C)(C)O)CC(=O)O,train
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1=O,DBMET02550,4-oxo-all-trans-retinoic acid,DBMET02552,4-oxo-13-cis-retinoic acid,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1=O,train
NCC(CC(=O)O)c1ccc(Cl)cc1,DB00181,Baclofen,DBMET02215,β-(p-chlorophenyl)-4-hydroxybutyric acid,C=C(CC(=O)O)c1ccc(Cl)cc1,train
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1,DB01413,Cefepime,DBMET03516,N-Methylpyrrolidine,CN1CCCC1,train
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)C1=C=C(Cl)OC(=O)c1ccco1,DBMET02370,"9-alpha,21-beta-dichloro-11-beta,21-alpha-dihydroxy-16-alpha-methylpregna-1,4,17,20-tetraen-3-one 21-(2-furoate)",DBMET02369,"21-beta-chloro-21-alpha-hydroxy-16-alpha-methyl-9-beta,11-beta-oxidopregna-1,4,17,20-tetraen-3-one 21-(2-furoate",C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]34O[C@H]4C[C@]2(C)C1=C=C(Cl)OC(=O)c1ccco1,train
Cc1cccc(C)c1NC(=O)CCO,DBMET02248,CVT-2535,DBMET02251,CVT-2537,Cc1cccc(C)c1NC(=O)CC(=O)O,train
Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2,DB00650,Leucovorin,DBMET00528,5-Methyltetrahydrofolate,CN1c2c(nc(N)[nH]c2=O)NCC1CNc1ccc(C(=O)N[C@H](CCC(=O)O)C(=O)O)cc1,train
c1ccc2c(N3CCNCC3)nsc2c1,DBMET02989,"3-(piperazine-1-yl)-1,2-benzisothiazole",DBMET02990,"3-(piperazine-1-yl)-1,2-benzisothiazole sulfoxide",O=S1N=C(N2CCNCC2)c2ccccc21,train
CCCCCCCCCCCCCCCCOCCCOP(=O)(O)CO[C@H](CO)Cn1ccc(N)nc1=O,DB12151,Brincidofovir,DB00369,Cidofovir,Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1,train
CCc1nn(CCCN2CCN(c3ccc(O)c(Cl)c3)CC2)c(=O)n1CC,DBMET02180,Etoperidone M5,DBMET02176,Etoperidone M8,CCn1c(C(C)O)nn(CCCN2CCN(c3ccc(O)c(Cl)c3)CC2)c1=O,val
CNCC/C=C1\c2ccccc2CSc2ccccc21,DBMET01516,Northiaden,DBMET01520,Northiaden S-oxide,CNCC/C=C1\c2ccccc2CS(=O)c2ccccc21,val
O=[N+]([O-])O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2O,DB01020,Isosorbide mononitrate,DB09401,Isosorbide,O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2O,val
CC1OC(C)OC(C)O1,DB09117,Paraldehyde,DBMET00328,acetaldehyde,CC=O,val
C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,DB01074,Perhexiline,DBMET00839,cis-Hydroxy Perhexiline,OC1CCC([C@@H](CC2CCCCN2)C2CCCCC2)CC1,val
CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C(O)C2C=C(O)[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,DBMET02473,Triol pravastatin,DBMET02474,"3-keto-5,6-diol pravastatin",CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C(O)C2=CC(=O)[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,val
C[C@H](C(=O)O)C(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O,DB04045,(R)-methylmalonyl-CoA,DB03699,Succinyl-Coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC(=O)O,val
O=S1(=O)N=C(N2CCNCC2)c2ccccc21,DBMET02991,"3-(piperazine-1-yl)-1,2-benzisothiazole sulfone",DBMET02992,"3-(piperazine-1-yl)-1,2-benzisothiazole sulfone lactam",O=C1CN(C2=NS(=O)(=O)c3ccccc32)CCN1,val
NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1,DB06448,Lonafarnib,DBMET03217,Lonafarnib metabolite M1,NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1O,val
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,DB01076,Atorvastatin,DBMET01268,Atorvastatin lactone,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)O,val
NC(N)=Nc1nc(CSCCC(N)=NS(N)(=O)=O)cs1,DB00927,Famotidine,DBMET02952,Famotidine S-oxide,NC(N)=Nc1nc(CS(=O)CCC(N)=NS(N)(=O)=O)cs1,val
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,DB00997,Doxorubicin,DBMET01078,Doxorubicine hydroxyaglycone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O,val
C=C(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1,DBMET01324,Nateglinide metabolite M7,DBMET01322,Nateglinide metabolite M11/M12,CC(O)(CO)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1,val
CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,DB00287,Travoprost,DBMET02216,Travoprost free acid,CC(C)OC(=O)CCC/C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O,val
O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,DB00586,Diclofenac,DBMET02617,diclofenac o-imine methine,C=C1C=CC=C/C1=N\c1c(Cl)cccc1Cl,val
C/C(=C/C(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12)SC[C@@H](N)C(=O)NCC(=O)O,DBMET02886,Acalabrutinib M7 Metabolite (ACP-5531),DBMET02887,Acalabrutinib M10 Metabolite (ACP-5461),C/C(=C/C(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12)SC[C@@H](N)C(=O)O,val
O=C1O[Pt]2(N[C@@H]3CCCC[C@H]3N2)OC1=O,DB00526,Oxaliplatin,DBMET03682,Monochloro DACH platinum,O=C(O)C(=O)O[Pt]1(Cl)N[C@@H]2CCCC[C@H]2N1,val
CC(=O)O.CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1cn(Cc2ccccc2)cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1,DB06788,Histrelin,DBMET03499,Histrelin metabolite,CC(C)C[C@H](NC(=O)[C@@H](Cc1cn(Cc2ccccc2)cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(N)=O,val
N=C(N)Nc1ccc(C(=O)Oc2ccc(CC(=O)O)cc2)cc1,DBMET03117,4-(4-guanidinobenzoyloxy)phenylacetic Acid,DBMET03118,4-guanidinobenzoic Acid,N=C(N)Nc1ccc(C(=O)O)cc1,val
OC(Cl)(Cl)C(c1ccc(Cl)cc1)c1ccccc1Cl,DBMET03760,Mitotane β-hydroxylated metabolite,DBMET03761,Mitotane acyl chloride metabolite,O=C(Cl)C(c1ccc(Cl)cc1)c1ccccc1Cl,val
NC(=O)N1c2ccccc2C=Cc2ccccc21,DB00564,Carbamazepine,DBMET00804,"Carbamazepine 2,3-epoxide",NC(=O)N1C2=CC3OC3C=C2C=Cc2ccccc21,val
CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O,DB00417,Phenoxymethylpenicillin,DBMET00983,Penicilloic acid,CC1(C)SC(C(NC(=O)Cc2ccccc2)C(=O)O)NC1C(=O)O,val
C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC,DB00957,Norgestimate,DBMET03015,17-desacetylnorgestimate,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC,val
CCCCCCCCCCC(=O)O,DBMET03460,Undecanoate,DBMET03175,Acetyl Coenzyme A,CC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O,val
OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,DB00742,Mannitol,DBMET00509,Glycogen,OC[C@H]1O[C@H](OC[C@H]2O[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@@H]2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,val
O=C1O[C@@H](CO)CN1c1ccc(-c2ccc(-c3nn[nH]n3)nc2)c(F)c1,DBMET03125,Desmethyl tedizolid,DBMET03124,Desmethyl tedizolid sulphate,O=C1O[C@@H](C=S(=O)([O-])[O-])CN1c1ccc(-c2ccc(-c3nn[nH]n3)nc2)c(F)c1,val
CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,DB01009,Ketoprofen,DBMET00589,Ketoprofen glucuronide,CC(C(=O)O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)c1cccc(C(=O)c2ccccc2)c1,val
NNc1n[nH]c(=O)c2ccccc12,DBMET02818,Hydrazinophthalazinone,DBMET02819,Acetylhydrazinophthalazinone,CC(=O)NNc1n[nH]c(=O)c2ccccc12,val
C[C@]12CCC(=O)C=C1C[C@@H](S)[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]21CCC(=O)O1,DBMET02481,7-alpha-thiospironolactone,DBMET02483,7-alpha-thiomethylspironolactone,CS[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,val
COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)CN1CC2,DB04844,Tetrabenazine,DBMET00800,b-dihydrotetrabenazine,COc1cc2c(cc1OC)C1CC(O)C(CC(C)C)CN1CC2,val
CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O,DB00542,Benazepril,DB14125,Benazeprilat,O=C(O)CN1C(=O)[C@@H](N[C@@H](CCc2ccccc2)C(=O)O)CCc2ccccc21,val
COc1ccc(Br)c(OC)c1C(=O)NC[C@@H]1CCCN1,,Remoxipride Metabolite FLA 838,DBMET03194,Remoxipride Metabolite NCL 118,COc1ccc(Br)c(OC)c1C(=O)NC[C@@H]1CCC(=O)N1,val
O=C1N[C@H](O)CCN1[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,DB15694,Cedazuridine,DBMET03186,"(4S)-2′-Deoxy-2′,2′-difluoro-3,4,5,6-tetrahydrouridine",O=C1N[C@@H](O)CCN1[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,val
C=CCC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](/C=C(/C)CO)C2(C)C)CC1=O,DBMET02076,M1 (Bioallethrin),DBMET02077,M2 (Bioallethrin),C=CCC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](/C=C(/C)C=O)C2(C)C)CC1=O,val
NC(CS[Pt]1(SCC(N)C(=O)O)N[C@@H]2CCCC[C@H]2N1)C(=O)O,DBMET03686,DACH platinum cysteine,DBMET03687,DACH platinum bis(Cys) complex,O=C(O)C1CS[Pt]23SCC(C(=O)O)N2[C@@H]2CCCC[C@H]2N13,val
CCc1nn(CCC[N+]2([O-])CC[N+]([O-])(c3cccc(Cl)c3)CC2)c(=O)n1CC,DBMET02179,Etoperidone M6,DBMET02177,Etoperidone M9,CCn1c(C(C)O)nn(CCC[N+]2([O-])CC[N+]([O-])(c3cccc(Cl)c3)CC2)c1=O,val
NC(=O)CNC(=O)c1cc(Cl)ccc1Cl,DBMET03786,Ixazomib M2 metabolite,DBMET03785,Ixazomib M1 metabolite,O=C(O)CNC(=O)c1cc(Cl)ccc1Cl,val
NCC(=O)NC(CCCCCNOC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)C(=O)NCC(=O)O,DBMET03072,Biotin Holocarboxylase Metabolite,DBMET03073,Biocytin,NC(CCCCCNOC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)C(=O)O,val
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,DB00694,Daunorubicin,DBMET03411,Deoxydaunorubicin aglycone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)O)CC3,val
COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2,DB11915,Valbenazine,DBMET01448,[+]-α-HTBZ,COc1cc2c(cc1OC)[C@H]1C[C@@H](O)[C@H](CC(C)C)CN1CC2,val
O=C1CCc2cc(O)c(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,DBMET02464,Aripiprazole unnamed metabolite 7,DBMET02465,Aripiprazole unnamed metabolite 8,O=C1CCC2=CC(=O)C(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)=CC2N1,val
N=C(N)NCc1cccc([123I])c1.N=C(N)NCc1cccc([123I])c1.O=S(=O)(O)O,DB09546,Iobenguane sulfate I-123,DBMET01492,m-Iodohippuric acid,O=C(O)CNC(=O)c1cccc([123I])c1,val
CC(O)[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CCC(O)O)[C@H]21,DBMET02476,3'(S)-hydroxy-pravastatin-tetranor,DBMET02477,3'(S)-hydroxy-pravastatin-tetranor glucuronide,CC(O)[C@H](C)C(=O)O[C@H]1C[C@H](OC2OC(C(=O)O)C(O)C(O)C2O)C=C2C=C[C@H](C)[C@H](CCC(O)O)[C@H]21,val
O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1OC(=O)c1cccnc1)c1cccnc1,DBMET01489,Inositol dinicotinate,DBMET01490,Inositol mononicotinate,O=C(O[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@@H]1O)c1cccnc1,val
NC(=O)NS(=O)(=O)c1ccc(Cl)cc1,DBMET00201,4-Chlorobenzenesulfonylurea,DBMET00977,4-Chlorobenzenesulfonamide,NS(=O)(=O)c1ccc(Cl)cc1,val
N#Cc1cc(-c2n[nH]c(-c3ccncc3)n2)ccn1,DB01685,Topiroxostat,DBMET01500,Topiroxostat N-oxide,N#Cc1cc(-c2n[nH]c(-c3cc[n+]([O-])cc3)n2)ccn1,val
CC1=CCC(C(C)(O)CO)CC1,DBMET01190,Uroterpenol,DBMET01191,Uroterpenol-O-glucuronide,CC1=CCC(C(C)(O)CO[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC1,val
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,DBMET03599,7-oxo-lithocholic acid,DB06777,Chenodeoxycholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,val
C1N2CN3CN1CN(C2)C3,DB06799,Methenamine,DBMET01432,ammonium,[NH4+],val
O=C(O)c1cc(O)c2c(c1)C(C1c3cc(C(=O)O)cc(O)c3C(=O)c3c(OC4OC(CO)C(O)C(O)C4O)cccc31)c1cccc(OC3OC(CO)C(O)C(O)C3O)c1C2=O,DB11365,Sennosides,DBMET01449,Sennidin A,O=C(O)c1cc(O)c2c(c1)C(C1c3cccc(O)c3C(=O)c3c(O)cc(C(=O)O)cc31)c1cccc(O)c1C2=O,val
CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12,DB01079,Tegaserod,DBMET02368,5-methoxyindole-3-carboxylic acid,COc1ccc2[nH]cc(C(=O)O)c2c1,val
COc1nc(N)nc2[nH]cnc12,DBMET03666,6-O-methylguanine,DB02377,Guanine,Nc1nc(=O)c2[nH]cnc2[nH]1,val
Nc1nc(=O)c2c([nH]1)NC[C@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O,DB11596,Levoleucovorin,DBMET00528,5-Methyltetrahydrofolate,CN1c2c(nc(N)[nH]c2=O)NCC1CNc1ccc(C(=O)N[C@H](CCC(=O)O)C(=O)O)cc1,val
